"","class","gene_id","Function.classification","function.","note.location","gene_name","Description","fc","log2.fc.","pval","qval","regulation","GO","KEGG","KO_ENTRY","EC","significant"
"4","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000003430","hypoxia"," a glycoprotein hormone in response to oxygen levels. increased erythropoiesis and enhanced oxygen-carrying capacity of the blood.","","EPO","erythropoietin ",2234.95,11.13,0,0,"up","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001666(response to hypoxia);GO:0005125(cytokine activity);GO:0005128(erythropoietin receptor binding);GO:0005179(hormone activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006915(apoptotic process);GO:0007566(embryo implantation);GO:0008283(cell population proliferation);GO:0008284(positive regulation of cell population proliferation);GO:0009986(cell surface);GO:0010469(regulation of signaling receptor activity);GO:0010523(negative regulation of calcium ion transport into cytosol);GO:0018105(peptidyl-serine phosphorylation);GO:0030218(erythrocyte differentiation);GO:0030295(protein kinase activator activity);GO:0032147(activation of protein kinase activity);GO:0033033(negative regulation of myeloid cell apoptotic process);GO:0038162(erythropoietin-mediated signaling pathway);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0042541(hemoglobin biosynthetic process);GO:0043066(negative regulation of apoptotic process);GO:0043249(erythrocyte maturation);GO:0045860(positive regulation of protein kinase activity);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046579(positive regulation of Ras protein signal transduction);GO:0071474(cellular hyperosmotic response);GO:1902219(negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress);GO:1902251(negative regulation of erythrocyte apoptotic process);GO:2001258(negative regulation of cation channel activity);GO:2001258(negative regulation of cation channel activity)","04060(Cytokine-cytokine receptor interaction);04066(HIF-1 signaling pathway);04151(PI3K-Akt signaling pathway);04630(Jak-STAT signaling pathway);04640(Hematopoietic cell lineage);05200(Pathways in cancer);05200(Pathways in cancer)","K05437",NA,"yes"
"5","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000019390","hypoxia-inducible marker"," catalyze the reversible hydration of carbon dioxide, CA12 was able to activate the mitochondrial apoptosis","","CA12","carbonic anhydrase 12 ",21.06,4.4,0,0,"up","GO:0004089(carbonate dehydratase activity);GO:0008270(zinc ion binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0046872(metal ion binding);GO:0055064(chloride ion homeostasis)","00910(Nitrogen metabolism)","K01672","EC:4.2.1.1","yes"
"6","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000011420","hypoxia-inducible marker"," catalyze the reversible hydration of carbon dioxide","","CA9","carbonic anhydrase 9 ",8.77,3.13,0,0,"up","GO:0002009(morphogenesis of an epithelium);GO:0004089(carbonate dehydratase activity);GO:0005886(plasma membrane);GO:0008270(zinc ion binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0046872(metal ion binding);GO:0046903(secretion)","00910(Nitrogen metabolism)","K01672","EC:4.2.1.1","yes"
"7","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000006261","hypoxia response","GPR17 may mediate hypoxia injury in RGC-5 cells, while the knockdown of GPR17 can reduce the hypoxia injury","","GPR17","G protein-coupled receptor 17 ",7.65,2.94,0,0,"up","GO:0002862(negative regulation of inflammatory response to antigenic stimulus);GO:0004930(G protein-coupled receptor activity);GO:0005887(integral component of plasma membrane);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0035025(positive regulation of Rho protein signal transduction);GO:0051482(positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway)",NA,"K08404",NA,"yes"
"8","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000021434","hypoxia","","","EDN2","endothelin 2 ",7.3,2.87,0,0,"up","GO:0001516(prostaglandin biosynthetic process);GO:0001659(temperature homeostasis);GO:0002690(positive regulation of leukocyte chemotaxis);GO:0003100(regulation of systemic arterial blood pressure by endothelin);GO:0005179(hormone activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005623(cell);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0008284(positive regulation of cell population proliferation);GO:0010460(positive regulation of heart rate);GO:0010469(regulation of signaling receptor activity);GO:0014824(artery smooth muscle contraction);GO:0014826(vein smooth muscle contraction);GO:0019221(cytokine-mediated signaling pathway);GO:0019229(regulation of vasoconstriction);GO:0019722(calcium-mediated signaling);GO:0030593(neutrophil chemotaxis);GO:0031708(endothelin B receptor binding);GO:0042116(macrophage activation);GO:0042310(vasoconstriction);GO:0045987(positive regulation of smooth muscle contraction);GO:0048016(inositol phosphate-mediated signaling);GO:0048246(macrophage chemotaxis);GO:0048286(lung alveolus development);GO:0050880(regulation of blood vessel size);GO:0060585(positive regulation of prostaglandin-endoperoxide synthase activity);GO:0097009(energy homeostasis)","04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction);04270(Vascular smooth muscle contraction);04924(Renin secretion)","K16367",NA,"yes"
"13","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000007273","iron transport/hypoxia response","iron transport/hypoxia response","","TF","transferrin ",4.52,2.18,0.03,0.07,"up","GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005769(early endosome);GO:0005770(late endosome);GO:0005905(clathrin-coated pit);GO:0006826(iron ion transport);GO:0006879(cellular iron ion homeostasis);GO:0008198(ferrous iron binding);GO:0008199(ferric iron binding);GO:0009925(basal plasma membrane);GO:0009986(cell surface);GO:0015091(ferric iron transmembrane transporter activity);GO:0016324(apical plasma membrane);GO:0030139(endocytic vesicle);GO:0031232(extrinsic component of external side of plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0031982(vesicle);GO:0034755(iron ion transmembrane transport);GO:0034756(regulation of iron ion transport);GO:0034986(iron chaperone activity);GO:0045178(basal part of cell);GO:0048260(positive regulation of receptor-mediated endocytosis);GO:0048471(perinuclear region of cytoplasm);GO:0055037(recycling endosome);GO:0071281(cellular response to iron ion);GO:0072512(trivalent inorganic cation transport);GO:1990459(transferrin receptor binding);GO:1990712(HFE-transferrin receptor complex)","04066(HIF-1 signaling pathway);04216(Ferroptosis);04978(Mineral absorption)","K14736",NA,"yes"
"14","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000008756","hypoxia response","hypoxia response, angiogenesis","","ELF3","E74 like ETS transcription factor 3 ",2.97,1.57,0,0,"up","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001824(blastocyst development);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003713(transcription coactivator activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006366(transcription by RNA polymerase II);GO:0006954(inflammatory response);GO:0009653(anatomical structure morphogenesis);GO:0030154(cell differentiation);GO:0030198(extracellular matrix organization);GO:0030855(epithelial cell differentiation);GO:0043565(sequence-specific DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0060056(mammary gland involution)",NA,"K09429",NA,"yes"
"16","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000010273","hypoxia"," regulating angiogenesis and vascular remodeling and by stimulating cell proliferation","","EREG","epiregulin ",0.39,-1.37,0,0,"down","GO:0001819(positive regulation of cytokine production);GO:0005154(epidermal growth factor receptor binding);GO:0005615(extracellular space);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007267(cell-cell signaling);GO:0008083(growth factor activity);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0009299(mRNA transcription);GO:0010469(regulation of signaling receptor activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019221(cytokine-mediated signaling pathway);GO:0042108(positive regulation of cytokine biosynthetic process);GO:0042327(positive regulation of phosphorylation);GO:0043616(keratinocyte proliferation);GO:0045089(positive regulation of innate immune response);GO:0045410(positive regulation of interleukin-6 biosynthetic process);GO:0045740(positive regulation of DNA replication);GO:0045840(positive regulation of mitotic nuclear division);GO:0045860(positive regulation of protein kinase activity);GO:0045892(negative regulation of transcription, DNA-templated);GO:0048146(positive regulation of fibroblast proliferation);GO:0051151(negative regulation of smooth muscle cell differentiation)","04010(MAPK signaling pathway);04012(ErbB signaling pathway);04151(PI3K-Akt signaling pathway);05210(Colorectal cancer)","K09784",NA,"yes"
"17","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000004221","hypoxia","Involved in angiogenesis; promotes angiogenic sprouting. ","","ESM1","endothelial cell specific molecule 1 ",0.33,-1.61,0,0,"down","GO:0001525(angiogenesis);GO:0002040(sprouting angiogenesis);GO:0005171(hepatocyte growth factor receptor binding);GO:0005178(integrin binding);GO:0005520(insulin-like growth factor binding);GO:0005576(extracellular region);GO:0008284(positive regulation of cell population proliferation);GO:1902204(positive regulation of hepatocyte growth factor receptor signaling pathway)",NA,NA,NA,"yes"
"18","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000002362","angiogenesis."," angiogenesis.","","APOLD1","apolipoprotein L domain containing 1 ",2.69,1.43,0,0,"up","GO:0001525(angiogenesis);GO:0005576(extracellular region);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006869(lipid transport);GO:0008289(lipid binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0042157(lipoprotein metabolic process);GO:0045601(regulation of endothelial cell differentiation)",NA,NA,NA,"yes"
"21","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000001078","autophagy?"," endocytosis and endosomal transport","","SRL","sarcalumenin ",8.55,3.1,0,0,"up","GO:0002115(store-operated calcium entry);GO:0005525(GTP binding);GO:0014873(response to muscle activity involved in regulation of muscle adaptation)",NA,NA,NA,"yes"
"22","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000021307","mitophagy/autophagy","argets mitochondria and causes apoptotic changes, including loss of membrane potential and the release of cytochrome c.","","BNIP3L","BCL2 interacting protein 3 like ",3.32,1.73,0,0,"up","GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005739(mitochondrion);GO:0005740(mitochondrial envelope);GO:0005741(mitochondrial outer membrane);GO:0005783(endoplasmic reticulum);GO:0006915(apoptotic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0035694(mitochondrial protein catabolic process);GO:0043065(positive regulation of apoptotic process);GO:0051607(defense response to virus);GO:0097345(mitochondrial outer membrane permeabilization)","04137(Mitophagy - animal)","K15465",NA,"yes"
"23","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000007431","autophagy?","autophagy?","endocytic vesicle; endoplasmic reticulum; and plasma membrane","CEMIP","cell migration inducing hyaluronidase 1 ",2.7,1.43,0,0,"up","GO:0004415(hyalurononglucosaminidase activity);GO:0005540(hyaluronic acid binding);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0007605(sensory perception of sound);GO:0010800(positive regulation of peptidyl-threonine phosphorylation);GO:0030214(hyaluronan catabolic process);GO:0030335(positive regulation of cell migration);GO:0030665(clathrin-coated vesicle membrane);GO:0032050(clathrin heavy chain binding);GO:0045334(clathrin-coated endocytic vesicle);GO:0046923(ER retention sequence binding);GO:0051281(positive regulation of release of sequestered calcium ion into cytosol);GO:0090314(positive regulation of protein targeting to membrane);GO:1900020(positive regulation of protein kinase C activity);GO:1900020(positive regulation of protein kinase C activity)",NA,"K19031","EC:3.2.1.35","yes"
"24","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000008625","autophagy"," positive regulation of autophagy","","PLEKHF1","pleckstrin homology and FYVE domain containing 1 ",2.62,1.39,0,0,"up","GO:0005764(lysosome);GO:0005768(endosome);GO:0007032(endosome organization);GO:0010314(phosphatidylinositol-5-phosphate binding);GO:0010508(positive regulation of autophagy);GO:0016050(vesicle organization);GO:0032266(phosphatidylinositol-3-phosphate binding);GO:0035091(phosphatidylinositol binding);GO:0046872(metal ion binding);GO:0070273(phosphatidylinositol-4-phosphate binding);GO:0072659(protein localization to plasma membrane);GO:2001244(positive regulation of intrinsic apoptotic signaling pathway)",NA,NA,NA,"yes"
"25","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000011209","autophagy","an E3 ubiquitin ligase that regulates proteasome-dependent protein degradation and mitochondrial autophagy","","SYT11","synaptotagmin 11 ",2.21,1.15,0,0,"up","GO:0000149(SNARE binding);GO:0001778(plasma membrane repair);GO:0001786(phosphatidylserine binding);GO:0001891(phagocytic cup);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0009611(response to wounding);GO:0014059(regulation of dopamine secretion);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016192(vesicle-mediated transport);GO:0017156(calcium ion regulated exocytosis);GO:0017158(regulation of calcium ion-dependent exocytosis);GO:0030276(clathrin binding);GO:0030424(axon);GO:0031369(translation initiation factor binding);GO:0031625(ubiquitin protein ligase binding);GO:0032009(early phagosome);GO:0042803(protein homodimerization activity);GO:0043005(neuron projection);GO:0045335(phagocytic vesicle);GO:0048487(beta-tubulin binding);GO:0048791(calcium ion-regulated exocytosis of neurotransmitter);GO:0050765(negative regulation of phagocytosis);GO:0051289(protein homotetramerization);GO:0055037(recycling endosome);GO:0070382(exocytic vesicle);GO:0071277(cellular response to calcium ion);GO:0098793(presynapse);GO:1900165(negative regulation of interleukin-6 secretion);GO:1900424(regulation of defense response to bacterium);GO:1904468(negative regulation of tumor necrosis factor secretion);GO:1905171(positive regulation of protein localization to phagocytic vesicle);GO:1990927(calcium ion regulated lysosome exocytosis);GO:1990927(calcium ion regulated lysosome exocytosis)",NA,"K19911",NA,"yes"
"26","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000006132","autophagy?","endosome to lysosome transport;","","DENND3","DENN domain containing 3 ",2.02,1.02,0,0,"up","GO:0005515(protein binding);GO:0008333(endosome to lysosome transport);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0044257(cellular protein catabolic process);GO:0044257(cellular protein catabolic process)",NA,"K20162",NA,"yes"
"27","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000017273","selective autophagy"," targeting DDX58/RIG-I for autophagic degradation","","LRRC25","leucine rich repeat containing 25 ",0,-8.77,0.03,0.07,"down","GO:0005515(protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane)",NA,NA,NA,"yes"
"28","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000049473","stress responses "," stress responses ","","OPRL1","opioid related nociceptin receptor 1 ",227,7.83,0.02,0.05,"up","GO:0001626(nociceptin receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0004985(opioid receptor activity);GO:0005887(integral component of plasma membrane);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane);GO:0019233(sensory perception of pain);GO:0038003(opioid receptor signaling pathway);GO:0051482(positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway)","04080(Neuroactive ligand-receptor interaction)","K04216",NA,"yes"
"29","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000046902","stress","mRNA translation and stability","","PABPC4L","poly(A) binding protein cytoplasmic 4 like ",11.14,3.48,0,0,"up","GO:0003676(nucleic acid binding);GO:0003723(RNA binding)","03013(RNA transport);03015(mRNA surveillance pathway);03018(RNA degradation)","K13126",NA,"yes"
"31","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000030674","ATP generation","A Key Regulator of Proliferation and Metabolic Shift via Akt and HIF-1alpha Signaling Pathways. an enzyme that transfers phosphate group among ATP/GTP, AMP, and ADP, is a key modulator of ATP ","mitochondrial matrix","AK4","adenylate kinase 4 ",2.49,1.31,0,0,"up","GO:0000166(nucleotide binding);GO:0004017(adenylate kinase activity);GO:0004550(nucleoside diphosphate kinase activity);GO:0005524(ATP binding);GO:0005525(GTP binding);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0006139(nucleobase-containing compound metabolic process);GO:0006165(nucleoside diphosphate phosphorylation);GO:0006172(ADP biosynthetic process);GO:0009142(nucleoside triphosphate biosynthetic process);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0016776(phosphotransferase activity, phosphate group as acceptor);GO:0019205(nucleobase-containing compound kinase activity);GO:0046033(AMP metabolic process);GO:0046034(ATP metabolic process);GO:0046039(GTP metabolic process);GO:0046899(nucleoside triphosphate adenylate kinase activity);GO:0046940(nucleoside monophosphate phosphorylation)","00230(Purine metabolism);00730(Thiamine metabolism)","K00939","EC:2.7.4.3","yes"
"32","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000012212","Mito metabolism/oxidative stress"," CYPs are usually membrane-bound and are localized to the inner mitochondrial or endoplasmic reticular membrane. CYPs have oxygenase activity","endoplasmic reticulum","CYP26B1","cytochrome P450, family 26, subfamily B, polypeptide 1 ",2.22,1.15,0,0,"up","GO:0001709(cell fate determination);GO:0001768(establishment of T cell polarity);GO:0001972(retinoic acid binding);GO:0004497(monooxygenase activity);GO:0005506(iron ion binding);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006805(xenobiotic metabolic process);GO:0006954(inflammatory response);GO:0007140(male meiotic nuclear division);GO:0007283(spermatogenesis);GO:0008401(retinoic acid 4-hydroxylase activity);GO:0009954(proximal/distal pattern formation);GO:0010628(positive regulation of gene expression);GO:0016020(membrane);GO:0016125(sterol metabolic process);GO:0016491(oxidoreductase activity);GO:0016705(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen);GO:0016709(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen);GO:0020037(heme binding);GO:0030326(embryonic limb morphogenesis);GO:0031090(organelle membrane);GO:0034653(retinoic acid catabolic process);GO:0043231(intracellular membrane-bounded organelle);GO:0043587(tongue morphogenesis);GO:0045580(regulation of T cell differentiation);GO:0046872(metal ion binding);GO:0048384(retinoic acid receptor signaling pathway);GO:0048385(regulation of retinoic acid receptor signaling pathway);GO:0048387(negative regulation of retinoic acid receptor signaling pathway);GO:0055114(oxidation-reduction process);GO:0060349(bone morphogenesis);GO:0061436(establishment of skin barrier);GO:0070268(cornification);GO:0071300(cellular response to retinoic acid);GO:2001037(positive regulation of tongue muscle cell differentiation)","00830(Retinol metabolism)","K12664",NA,"yes"
"33","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000008133","mito metabolism/oxidative stress","Dioxygenase that acts as on nucleic acids, such as DNA and tRNA¡£In mitochondrion, specifically interacts with mt-tRNA(Met) and mediates oxidation of mt-tRNA(Met) methylated at cytosine(34) to form 5-formylcytosine (f(5)c) at this position. ALKBH1 promotes lung cancer by regulating m6A RNA demethylation. ","","ALKBH1","alkB homolog 1, histone H2A dioxygenase ",0.5,-1,0,0,"down","GO:0000049(tRNA binding);GO:0001701(in utero embryonic development);GO:0001764(neuron migration);GO:0001890(placenta development);GO:0002101(tRNA wobble cytosine modification);GO:0005719(nuclear euchromatin);GO:0005739(mitochondrion);GO:0006281(DNA repair);GO:0006307(DNA dealkylation involved in DNA repair);GO:0006446(regulation of translational initiation);GO:0006448(regulation of translational elongation);GO:0008198(ferrous iron binding);GO:0010468(regulation of gene expression);GO:0016491(oxidoreductase activity);GO:0016706(2-oxoglutarate-dependent dioxygenase activity);GO:0030154(cell differentiation);GO:0031175(neuron projection development);GO:0035511(oxidative DNA demethylation);GO:0035516(oxidative DNA demethylase activity);GO:0042056(chemoattractant activity);GO:0042245(RNA repair);GO:0043524(negative regulation of neuron apoptotic process);GO:0048589(developmental growth);GO:0050918(positive chemotaxis);GO:0051213(dioxygenase activity);GO:0055114(oxidation-reduction process);GO:0070129(regulation of mitochondrial translation);GO:0070579(methylcytosine dioxygenase activity);GO:0070989(oxidative demethylation);GO:0080111(DNA demethylation);GO:0140078(class I DNA-(apurinic or apyrimidinic site) endonuclease activity);GO:1990983(tRNA demethylation);GO:1990984(tRNA demethylase activity)",NA,"K10765","1.14.11.-;4.2.99.18;EC:1.14.11.51","yes"
"34","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000001945","immune/oxidative stress","mitochondrial form, it catalyzes the hydrolysis of arginine to ornithine and urea."," mitochondria","ARG2","arginase 2 ",0.47,-1.07,0,0,"down","GO:0000050(urea cycle);GO:0001657(ureteric bud development);GO:0002829(negative regulation of type 2 immune response);GO:0004053(arginase activity);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0006525(arginine metabolic process);GO:0006941(striated muscle contraction);GO:0016787(hydrolase activity);GO:0016813(hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines);GO:0019547(arginine catabolic process to ornithine);GO:0030145(manganese ion binding);GO:0032720(negative regulation of tumor necrosis factor production);GO:0046872(metal ion binding);GO:0050706(regulation of interleukin-1 beta secretion);GO:0071641(negative regulation of macrophage inflammatory protein 1 alpha production);GO:0071644(negative regulation of chemokine (C-C motif) ligand 4 production);GO:0071650(negative regulation of chemokine (C-C motif) ligand 5 production);GO:1900425(negative regulation of defense response to bacterium);GO:1903426(regulation of reactive oxygen species biosynthetic process);GO:1904468(negative regulation of tumor necrosis factor secretion);GO:1905077(negative regulation of interleukin-17 secretion);GO:1905403(negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process);GO:2000562(negative regulation of CD4-positive, alpha-beta T cell proliferation);GO:2000666(negative regulation of interleukin-13 secretion);GO:2000774(positive regulation of cellular senescence);GO:2000774(positive regulation of cellular senescence)","00220(Arginine biosynthesis);00330(Arginine and proline metabolism);05146(Amoebiasis);05146(Amoebiasis)","K01476","EC:3.5.3.1","yes"
"35","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000012592","stress","DNA damage response and DNA repair","","ANKLE1","ankyrin repeat and LEM domain containing 1 ",0.46,-1.13,0,0,"down","GO:0004519(endonuclease activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006611(protein export from nucleus);GO:0090305(nucleic acid phosphodiester bond hydrolysis);GO:2001022(positive regulation of response to DNA damage stimulus)",NA,"K21411",NA,"yes"
"36","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000013162","stress","","","HSPA8","heat shock protein family A (Hsp70) member 8 ",0.44,-1.17,0,0,"down","GO:0000151(ubiquitin ligase complex);GO:0000166(nucleotide binding);GO:0000974(Prp19 complex);GO:0001664(G protein-coupled receptor binding);GO:0001786(phosphatidylserine binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005681(spliceosomal complex);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005770(late endosome);GO:0005776(autophagosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006397(mRNA processing);GO:0006457(protein folding);GO:0006986(response to unfolded protein);GO:0008088(axo-dendritic transport);GO:0008380(RNA splicing);GO:0016020(membrane);GO:0016191(synaptic vesicle uncoating);GO:0016192(vesicle-mediated transport);GO:0016887(ATPase activity);GO:0019899(enzyme binding);GO:0030424(axon);GO:0030425(dendrite);GO:0030674(protein binding, bridging);GO:0031072(heat shock protein binding);GO:0031625(ubiquitin protein ligase binding);GO:0031647(regulation of protein stability);GO:0034605(cellular response to heat);GO:0034620(cellular response to unfolded protein);GO:0042026(protein refolding);GO:0042470(melanosome);GO:0042623(ATPase activity, coupled);GO:0043195(terminal bouton);GO:0044183(protein folding chaperone);GO:0044788(modulation by host of viral process);GO:0044829(positive regulation by host of viral genome replication);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046034(ATP metabolic process);GO:0048026(positive regulation of mRNA splicing, via spliceosome);GO:0048471(perinuclear region of cytoplasm);GO:0051082(unfolded protein binding);GO:0051085(chaperone cofactor-dependent protein refolding);GO:0051087(chaperone binding);GO:0051726(regulation of cell cycle);GO:0051787(misfolded protein binding);GO:0055131(C3HC4-type RING finger domain binding);GO:0061077(chaperone-mediated protein folding);GO:0061738(late endosomal microautophagy);GO:0061740(protein targeting to lysosome involved in chaperone-mediated autophagy);GO:0061741(chaperone-mediated protein transport involved in chaperone-mediated autophagy);GO:0070062(extracellular exosome);GO:0072318(clathrin coat disassembly);GO:0098684(photoreceptor ribbon synapse);GO:0098690(glycinergic synapse);GO:0098793(presynapse);GO:0098978(glutamatergic synapse);GO:0099175(regulation of postsynapse organization);GO:0099523(presynaptic cytosol);GO:0099524(postsynaptic cytosol);GO:0099634(postsynaptic specialization membrane);GO:0101031(chaperone complex);GO:1902904(negative regulation of supramolecular fiber organization);GO:1904764(chaperone-mediated autophagy translocation complex disassembly);GO:1990832(slow axonal transport);GO:1990833(clathrin-uncoating ATPase activity);GO:1990904(ribonucleoprotein complex);GO:1990904(ribonucleoprotein complex)","03040(Spliceosome);04010(MAPK signaling pathway);04141(Protein processing in endoplasmic reticulum);04144(Endocytosis);04213(Longevity regulating pathway - multiple species);04612(Antigen processing and presentation);04915(Estrogen signaling pathway);05134(Legionellosis);05145(Toxoplasmosis);05162(Measles);05164(Influenza A);05164(Influenza A)","K03283",NA,"yes"
"37","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000014151","stress/ cell growth","Stress-induced phosphorylation of CAPZIP may regulate the ability of F-actin-capping protein to remodel actin filament assembly","","RCSD1","RCSD domain containing 1 ",0.42,-1.24,0.01,0.02,"down","GO:0051015(actin filament binding);GO:0071474(cellular hyperosmotic response)",NA,"K18615",NA,"yes"
"38","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000052665","Mito metabolism/oxidative stress","","","CYP3A4","cytochrome P450, subfamily IIIA, polypeptide 4 ",0.39,-1.38,0,0,"down","GO:0004497(monooxygenase activity);GO:0005506(iron ion binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016491(oxidoreductase activity);GO:0016705(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen);GO:0016712(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen);GO:0020037(heme binding);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process)","00140(Steroid hormone biosynthesis);00591(Linoleic acid metabolism);00830(Retinol metabolism);04976(Bile secretion);05204(Chemical carcinogenesis)","K07424","EC:1.14.14.1","yes"
"39","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000053645","Mito metabolism/oxidative stress","","","CYP3A5","cytochrome P450, family 3, subfamily A, polypeptide 5 ",0.11,-3.12,0.02,0.05,"down","GO:0004497(monooxygenase activity);GO:0005506(iron ion binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016491(oxidoreductase activity);GO:0016705(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen);GO:0016712(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen);GO:0020037(heme binding);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process)","00140(Steroid hormone biosynthesis);00591(Linoleic acid metabolism);00830(Retinol metabolism);05204(Chemical carcinogenesis)","K07424","EC:1.14.14.1","yes"
"40","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000011224","HIF-1 signaling","egative regulator for hypoxia-inducible 1a, it inhibits transactivation of HIF1A-induced genes by competing with binding of hypoxia-inducible factor 1-alpha to p300-CH1.","","CITED2","Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2 ",2.21,1.14,0,0,"up","GO:0000790(nuclear chromatin);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0001568(blood vessel development);GO:0001570(vasculogenesis);GO:0001666(response to hypoxia);GO:0001701(in utero embryonic development);GO:0001829(trophectodermal cell differentiation);GO:0001841(neural tube formation);GO:0001843(neural tube closure);GO:0001889(liver development);GO:0001892(embryonic placenta development);GO:0001944(vasculature development);GO:0001947(heart looping);GO:0002089(lens morphogenesis in camera-type eye);GO:0002244(hematopoietic progenitor cell differentiation);GO:0002521(leukocyte differentiation);GO:0003151(outflow tract morphogenesis);GO:0003156(regulation of animal organ formation);GO:0003197(endocardial cushion development);GO:0003281(ventricular septum development);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0003713(transcription coactivator activity);GO:0003714(transcription corepressor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007275(multicellular organism development);GO:0007368(determination of left/right symmetry);GO:0007417(central nervous system development);GO:0007422(peripheral nervous system development);GO:0007507(heart development);GO:0007530(sex determination);GO:0008584(male gonad development);GO:0021602(cranial nerve morphogenesis);GO:0022409(positive regulation of cell-cell adhesion);GO:0030154(cell differentiation);GO:0030325(adrenal gland development);GO:0030511(positive regulation of transforming growth factor beta receptor signaling pathway);GO:0030851(granulocyte differentiation);GO:0035360(positive regulation of peroxisome proliferator activated receptor signaling pathway);GO:0035802(adrenal cortex formation);GO:0035914(skeletal muscle cell differentiation);GO:0043066(negative regulation of apoptotic process);GO:0043627(response to estrogen);GO:0045787(positive regulation of cell cycle);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046332(SMAD binding);GO:0046697(decidualization);GO:0048536(spleen development);GO:0048538(thymus development);GO:0048596(embryonic camera-type eye morphogenesis);GO:0048821(erythrocyte development);GO:0060136(embryonic process involved in female pregnancy);GO:0060349(bone morphogenesis);GO:0060411(cardiac septum morphogenesis);GO:0060412(ventricular septum morphogenesis);GO:0060971(embryonic heart tube left/right pattern formation);GO:0061156(pulmonary artery morphogenesis);GO:0061308(cardiac neural crest cell development involved in heart development);GO:0061371(determination of heart left/right asymmetry);GO:0070986(left/right axis specification);GO:1900164(nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry);GO:1903507(negative regulation of nucleic acid-templated transcription);GO:2000020(positive regulation of male gonad development)","04137(Mitophagy - animal)","K21361",NA,"yes"
"42","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000018453","HIF-1 traget","ANKRD37 as a novel HIF-1-target gene","cytosol; mitochondrion; and nucleoplasm","ANKRD37","ankyrin repeat domain 37 ",13.04,3.7,0,0,"up","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol)",NA,NA,NA,"yes"
"43","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000038757","oxygen binding","","","HBM","hemoglobin subunit mu ",2074.99,11.02,0,0,"up","GO:0004601(peroxidase activity);GO:0005344(oxygen carrier activity);GO:0005515(protein binding);GO:0005833(hemoglobin complex);GO:0015671(oxygen transport);GO:0019825(oxygen binding);GO:0020037(heme binding);GO:0031720(haptoglobin binding);GO:0031838(haptoglobin-hemoglobin complex);GO:0042744(hydrogen peroxide catabolic process);GO:0043177(organic acid binding);GO:0046872(metal ion binding);GO:0051291(protein heterooligomerization);GO:0098869(cellular oxidant detoxification)",NA,"K13828",NA,"yes"
"44","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000038921","oxygen sensing","Zeta-globin is an alpha-like hemoglobin.","HBZ","ENSBTAG00000038921","hemoglobin subunit zeta ",1927.28,10.91,0.02,0.04,"up","GO:0004601(peroxidase activity);GO:0005344(oxygen carrier activity);GO:0005506(iron ion binding);GO:0005515(protein binding);GO:0005833(hemoglobin complex);GO:0015671(oxygen transport);GO:0019825(oxygen binding);GO:0020037(heme binding);GO:0031720(haptoglobin binding);GO:0031838(haptoglobin-hemoglobin complex);GO:0042744(hydrogen peroxide catabolic process);GO:0043177(organic acid binding);GO:0046872(metal ion binding);GO:0051291(protein heterooligomerization);GO:0098869(cellular oxidant detoxification)",NA,"K13826",NA,"yes"
"45","Hypoxia-related responses (mitophagy/autophagy/stresses)","","","","","","",NA,NA,NA,NA,"","","","","",""
"46","Hypoxia-related responses (mitophagy/autophagy/stresses)","Glucose metabolism","","","","","",NA,NA,NA,NA,"","","","","",""
"47","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000001032","glucose metabolism","rate-limiting step in glycogen catabolism.phosphorolytic cleavage of glycogen to produce glucose-1-phosphate,","","PYGM","glycogen phosphorylase, muscle associated ",237.85,7.89,0.01,0.03,"up","GO:0004645(phosphorylase activity);GO:0005737(cytoplasm);GO:0005975(carbohydrate metabolic process);GO:0005980(glycogen catabolic process);GO:0008184(glycogen phosphorylase activity);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0030170(pyridoxal phosphate binding);GO:0102250(linear malto-oligosaccharide phosphorylase activity);GO:0102499(SHG alpha-glucan phosphorylase activity)","00500(Starch and sucrose metabolism);04217(Necroptosis);04910(Insulin signaling pathway);04922(Glucagon signaling pathway);04931(Insulin resistance)","K00688","EC:2.4.1.1","yes"
"50","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000018647","glucose metabolism","glucose and fructose transport","","SLC2A11","solute carrier family 2 member 11 ",5.23,2.39,0,0.01,"up","GO:0005215(transporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport);GO:0055085(transmembrane transport)",NA,"K08148",NA,"yes"
"52","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000013099","Glycolysis/Gluconeogenesis"," a member of the class I fructose-biphosphate aldolase gene family","","ALDOC","aldolase, fructose-bisphosphate C ",4.31,2.11,0,0,"up","GO:0003824(catalytic activity);GO:0004332(fructose-bisphosphate aldolase activity);GO:0006096(glycolytic process);GO:0008092(cytoskeletal protein binding);GO:0016829(lyase activity);GO:0030388(fructose 1,6-bisphosphate metabolic process);GO:0030855(epithelial cell differentiation)","00010(Glycolysis / Gluconeogenesis);00030(Pentose phosphate pathway);00051(Fructose and mannose metabolism)","K01623","EC:4.1.2.13","yes"
"53","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000020481","glucose metabolism","glycosylation, elongates O-linked glucose bound to epidermal growth factor (EGF) repeats","","GXYLT2","glucoside xylosyltransferase 2 ",3.12,1.64,0,0,"up","GO:0016266(O-glycan processing);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0035252(UDP-xylosyltransferase activity)","00514(Other types of O-glycan biosynthesis)","K13676","EC:2.4.2.-","yes"
"54","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000019782","glycolysis and gluconeogenesis.","catalyzes the isomerization of glyceraldehydes 3-phosphate (G3P) and dihydroxy-acetone phosphate (DHAP)","","TPI1","triosephosphate isomerase 1 ",2.34,1.23,0,0,"up","GO:0003824(catalytic activity);GO:0004807(triose-phosphate isomerase activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006006(glucose metabolic process);GO:0006094(gluconeogenesis);GO:0006096(glycolytic process);GO:0007275(multicellular organism development);GO:0008929(methylglyoxal synthase activity);GO:0016829(lyase activity);GO:0016853(isomerase activity);GO:0019242(methylglyoxal biosynthetic process);GO:0019563(glycerol catabolic process);GO:0019682(glyceraldehyde-3-phosphate metabolic process);GO:0031625(ubiquitin protein ligase binding);GO:0042803(protein homodimerization activity);GO:0046166(glyceraldehyde-3-phosphate biosynthetic process)","00010(Glycolysis / Gluconeogenesis);00051(Fructose and mannose metabolism);00562(Inositol phosphate metabolism)","K01803","EC:5.3.1.1","yes"
"55","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000039197","glucose metabolism","low-capacity glucose and fructose transporter activity","","SLC2A9","solute carrier family 2 member 9 ",2.18,1.12,0,0,"up","GO:0005215(transporter activity);GO:0005355(glucose transmembrane transporter activity);GO:0005886(plasma membrane);GO:0015143(urate transmembrane transporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0046415(urate metabolic process);GO:0055085(transmembrane transport);GO:1904659(glucose transmembrane transport);GO:1904659(glucose transmembrane transport)",NA,"K08146",NA,"yes"
"56","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000012927","Glycolysis/Gluconeogenesis","Catalyzes the reversible conversion of beta-D-fructose 1,6-bisphosphate (FBP) into two triose phosphate","","ALDOA","aldolase, fructose-bisphosphate A ",2.03,1.02,0,0,"up","GO:0003824(catalytic activity);GO:0004332(fructose-bisphosphate aldolase activity);GO:0006096(glycolytic process);GO:0016829(lyase activity);GO:0016829(lyase activity)","00010(Glycolysis / Gluconeogenesis);00030(Pentose phosphate pathway);00051(Fructose and mannose metabolism);00051(Fructose and mannose metabolism)","K01623","EC:4.1.2.13","yes"
"57","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000003074","glucose metabolism/glycolysis","monocarboxylic acid transport.  such as lactate, pyruvate, branched-chain oxo acids derived from leucine, valine and isoleucine,and the ketone bodies acetoacetate, beta-hydroxybutyrate and acetate","","SLC16A6","solute carrier family 16 member 6 ",0.46,-1.12,0,0,"down","GO:0005887(integral component of plasma membrane);GO:0008028(monocarboxylic acid transmembrane transporter activity);GO:0015718(monocarboxylic acid transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport)",NA,"K08183",NA,"yes"
"58","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000005386","glucose metabolism","Facilitative hexose transporter that mediates the transport of glucose, fructose and galactose","GluT2","SLC2A2","solute carrier family 2 member 2 ",0.21,-2.28,0,0,"down","GO:0005215(transporter activity);GO:0005355(glucose transmembrane transporter activity);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005903(brush border);GO:0005911(cell-cell junction);GO:0008643(carbohydrate transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016324(apical plasma membrane);GO:0022857(transmembrane transporter activity);GO:0033300(dehydroascorbic acid transmembrane transporter activity);GO:0055056(D-glucose transmembrane transporter activity);GO:0055085(transmembrane transport);GO:0070837(dehydroascorbic acid transport);GO:1904659(glucose transmembrane transport);GO:1904659(glucose transmembrane transport)","04911(Insulin secretion);04917(Prolactin signaling pathway);04922(Glucagon signaling pathway);04930(Type II diabetes mellitus);04931(Insulin resistance);04950(Maturity onset diabetes of the young);04973(Carbohydrate digestion and absorption);05230(Central carbon metabolism in cancer);05230(Central carbon metabolism in cancer)","K07593",NA,"yes"
"59","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000012434","ETC","involved in plasma membrane electron transport pathways, reducing nicotinamide adenine dinucleotide (NAD+) to NADH","","ENOX1","ecto-NOX disulfide-thiol exchanger 1 ",792.34,9.63,0,0,"up","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005886(plasma membrane);GO:0007624(ultradian rhythm);GO:0009897(external side of plasma membrane);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)",NA,NA,NA,"yes"
"60","Hypoxia-related responses (mitophagy/autophagy/stresses)","ENSBTAG00000003174","ETC/OXPHOS"," translocation of protons across the inner mitochondrial membrane","","NDUFAF4","NADH:ubiquinone oxidoreductase complex assembly factor 4 ",0.47,-1.1,0,0,"down","GO:0005516(calmodulin binding);GO:0005739(mitochondrion);GO:0010257(NADH dehydrogenase complex assembly);GO:0016020(membrane);GO:0031966(mitochondrial membrane);GO:0032981(mitochondrial respiratory chain complex I assembly)","04714(Thermogenesis)","K18161",NA,"yes"
"66","Lipid metabolism","ENSBTAG00000002473","glucose/lipid metabolism","modulating triacylglycerol homeostasis","","ANGPTL4","angiopoietin like 4 ",9.34,3.22,0,0,"up","GO:0001525(angiogenesis);GO:0004857(enzyme inhibitor activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0007275(multicellular organism development);GO:0030154(cell differentiation);GO:0042802(identical protein binding);GO:0043066(negative regulation of apoptotic process);GO:0051005(negative regulation of lipoprotein lipase activity);GO:0070328(triglyceride homeostasis);GO:2000352(negative regulation of endothelial cell apoptotic process);GO:2000352(negative regulation of endothelial cell apoptotic process)","03320(PPAR signaling pathway);04979(Cholesterol metabolism);04979(Cholesterol metabolism)","K08767",NA,"yes"
"68","Lipid metabolism","ENSBTAG00000019980","lipid metabolism"," regulate the intracellular concentration of diacylglycerol through its phosphorylation","","DGKI","diacylglycerol kinase iota ",2.52,1.34,0,0,"up","GO:0000166(nucleotide binding);GO:0003951(NAD+ kinase activity);GO:0004143(diacylglycerol kinase activity);GO:0005095(GTPase inhibitor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0007165(signal transduction);GO:0007205(protein kinase C-activating G protein-coupled receptor signaling pathway);GO:0007269(neurotransmitter secretion);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0017016(Ras GTPase binding);GO:0032045(guanyl-nucleotide exchange factor complex);GO:0032991(protein-containing complex);GO:0035556(intracellular signal transduction);GO:0043087(regulation of GTPase activity);GO:0043197(dendritic spine);GO:0045202(synapse);GO:0046339(diacylglycerol metabolic process);GO:0046486(glycerolipid metabolic process);GO:0046579(positive regulation of Ras protein signal transduction);GO:0046834(lipid phosphorylation);GO:0046959(habituation);GO:0048471(perinuclear region of cytoplasm);GO:0051966(regulation of synaptic transmission, glutamatergic);GO:0060079(excitatory postsynaptic potential);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098978(glutamatergic synapse);GO:1900452(regulation of long-term synaptic depression);GO:2000300(regulation of synaptic vesicle exocytosis)","00561(Glycerolipid metabolism);00564(Glycerophospholipid metabolism);04070(Phosphatidylinositol signaling system);04072(Phospholipase D signaling pathway);05231(Choline metabolism in cancer)","K00901","EC:2.7.1.107","yes"
"69","Lipid metabolism","ENSBTAG00000024387","lipid metabolism","catalyze the cleavage of fatty acids from membrane phospholipids","","PNPLA8","patatin like phospholipase domain containing 8 ",2.42,1.28,0,0,"up","GO:0001516(prostaglandin biosynthetic process);GO:0005777(peroxisome);GO:0005778(peroxisomal membrane);GO:0006629(lipid metabolic process);GO:0006631(fatty acid metabolic process);GO:0008219(cell death);GO:0016020(membrane);GO:0016042(lipid catabolic process);GO:0016787(hydrolase activity);GO:0019369(arachidonic acid metabolic process);GO:0034638(phosphatidylcholine catabolic process);GO:0043651(linoleic acid metabolic process);GO:0046338(phosphatidylethanolamine catabolic process);GO:0047499(calcium-independent phospholipase A2 activity);GO:0050482(arachidonic acid secretion)",NA,"K16815",NA,"yes"
"70","Lipid metabolism","ENSBTAG00000018041","Lipid metabolism","catalyze the dehydrogenation of acyl-CoA derivatives in the metabolism of fatty acids or branch chained amino acids","","ACADSB","acyl-CoA dehydrogenase short/branched chain ",2.34,1.23,0.01,0.03,"up","GO:0003995(acyl-CoA dehydrogenase activity);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0006629(lipid metabolic process);GO:0006631(fatty acid metabolic process);GO:0016491(oxidoreductase activity);GO:0016627(oxidoreductase activity, acting on the CH-CH group of donors);GO:0050660(flavin adenine dinucleotide binding);GO:0055114(oxidation-reduction process)","00071(Fatty acid degradation);00280(Valine, leucine and isoleucine degradation)","K09478","EC:1.3.99.12","yes"
"72","Lipid metabolism","ENSBTAG00000039686","Lipid metabolism","the conversion of activated fatty acids to the corresponding non-esterified fatty acid and coenzyme A","","ACOT11","acyl-CoA thioesterase 11 ",2.07,1.05,0,0,"up","GO:0000062(fatty-acyl-CoA binding);GO:0005829(cytosol);GO:0006637(acyl-CoA metabolic process);GO:0008289(lipid binding);GO:0016290(palmitoyl-CoA hydrolase activity);GO:0016787(hydrolase activity);GO:0016790(thiolester hydrolase activity);GO:0036042(long-chain fatty acyl-CoA binding);GO:0047617(acyl-CoA hydrolase activity);GO:1900535(palmitic acid biosynthetic process);GO:1900535(palmitic acid biosynthetic process)",NA,NA,NA,"yes"
"73","Lipid metabolism","ENSBTAG00000008124","lipid metabolism","glycerol uptake and metabolism","","GK","glycerol kinase ",0.49,-1.04,0,0,"down","GO:0000166(nucleotide binding);GO:0004370(glycerol kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005975(carbohydrate metabolic process);GO:0006071(glycerol metabolic process);GO:0006072(glycerol-3-phosphate metabolic process);GO:0006641(triglyceride metabolic process);GO:0016020(membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0016773(phosphotransferase activity, alcohol group as acceptor);GO:0019563(glycerol catabolic process);GO:0046167(glycerol-3-phosphate biosynthetic process);GO:0046167(glycerol-3-phosphate biosynthetic process)","00561(Glycerolipid metabolism);03320(PPAR signaling pathway);03320(PPAR signaling pathway)","K00864","EC:2.7.1.30","yes"
"74","Lipid metabolism","ENSBTAG00000019625","Lipid metabolism","?peroxisomal beta-oxidation pathway","","EHHADH","enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase ",0.48,-1.05,0,0,"down","GO:0003824(catalytic activity);GO:0003857(3-hydroxyacyl-CoA dehydrogenase activity);GO:0005102(signaling receptor binding);GO:0005777(peroxisome);GO:0006475(internal protein amino acid acetylation);GO:0006631(fatty acid metabolic process);GO:0006635(fatty acid beta-oxidation);GO:0016491(oxidoreductase activity);GO:0019899(enzyme binding);GO:0055114(oxidation-reduction process);GO:0055114(oxidation-reduction process)","00071(Fatty acid degradation);00280(Valine, leucine and isoleucine degradation);00310(Lysine degradation);00380(Tryptophan metabolism);00410(beta-Alanine metabolism);00640(Propanoate metabolism);00650(Butanoate metabolism);03320(PPAR signaling pathway);04146(Peroxisome);04146(Peroxisome)","K07514","1.1.1.35;5.3.3.8;EC:4.2.1.17","yes"
"75","Lipid metabolism","ENSBTAG00000017567","Lipid metabolism"," catalyzes the carboxylation of acetyl-CoA to malonyl-CoA, the rate-limiting step in fatty acid synthesis.","","ACACA","acetyl-CoA carboxylase alpha ",0.43,-1.23,0,0,"down","GO:0000166(nucleotide binding);GO:0001650(fibrillar center);GO:0001894(tissue homeostasis);GO:0003989(acetyl-CoA carboxylase activity);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0006084(acetyl-CoA metabolic process);GO:0006629(lipid metabolic process);GO:0006633(fatty acid biosynthetic process);GO:0015629(actin cytoskeleton);GO:0016874(ligase activity);GO:0019538(protein metabolic process);GO:0042802(identical protein binding);GO:0046872(metal ion binding);GO:0051289(protein homotetramerization);GO:0055088(lipid homeostasis);GO:0071380(cellular response to prostaglandin E stimulus);GO:0071380(cellular response to prostaglandin E stimulus)","00061(Fatty acid biosynthesis);00620(Pyruvate metabolism);00640(Propanoate metabolism);04152(AMPK signaling pathway);04910(Insulin signaling pathway);04922(Glucagon signaling pathway);04922(Glucagon signaling pathway)","K11262","2.1.3.15;6.3.4.14;EC:6.4.1.2","yes"
"76","Lipid metabolism","ENSBTAG00000015498","Lipid metabolism","participate in the biosynthesis of fatty acids","","ELOVL4","ELOVL fatty acid elongase 4 ",0.33,-1.58,0,0,"down","GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006629(lipid metabolic process);GO:0006631(fatty acid metabolic process);GO:0006633(fatty acid biosynthetic process);GO:0006636(unsaturated fatty acid biosynthetic process);GO:0009922(fatty acid elongase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0019367(fatty acid elongation, saturated fatty acid);GO:0030148(sphingolipid biosynthetic process);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0034625(fatty acid elongation, monounsaturated fatty acid);GO:0034626(fatty acid elongation, polyunsaturated fatty acid);GO:0035338(long-chain fatty-acyl-CoA biosynthetic process);GO:0042761(very long-chain fatty acid biosynthetic process);GO:0102336(3-oxo-arachidoyl-CoA synthase activity);GO:0102337(3-oxo-cerotoyl-CoA synthase activity);GO:0102338(3-oxo-lignoceronyl-CoA synthase activity);GO:0102756(very-long-chain 3-ketoacyl-CoA synthase activity)","00062(Fatty acid elongation);01040(Biosynthesis of unsaturated fatty acids)","K10249","EC:2.3.1.199","yes"
"77","Lipid metabolism","ENSBTAG00000006896","Lipid metabolism","transport various molecules across extra- and intracellular membranes","","ABCA9","ATP binding cassette subfamily A member 9 ",0.01,-6.83,0.05,0.11,"down","GO:0000166(nucleotide binding);GO:0005319(lipid transporter activity);GO:0005524(ATP binding);GO:0006869(lipid transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016887(ATPase activity);GO:0042626(ATPase activity, coupled to transmembrane movement of substances);GO:0043231(intracellular membrane-bounded organelle);GO:0055085(transmembrane transport)","02010(ABC transporters)","K05651",NA,"yes"
"78","Lipid metabolism","ENSBTAG00000004297","Lipid metabolism/mito£¿"," breakdown of certain fat molecules called very long-chain fatty acids (VLCFAs)","peroxisome","ACOXL","acyl-CoA oxidase like ",0,-8.61,0.03,0.07,"down","GO:0003997(acyl-CoA oxidase activity);GO:0005504(fatty acid binding);GO:0005777(peroxisome);GO:0006631(fatty acid metabolic process);GO:0006635(fatty acid beta-oxidation);GO:0016627(oxidoreductase activity, acting on the CH-CH group of donors);GO:0033540(fatty acid beta-oxidation using acyl-CoA oxidase);GO:0050660(flavin adenine dinucleotide binding);GO:0055088(lipid homeostasis);GO:0055114(oxidation-reduction process);GO:0071949(FAD binding);GO:0071949(FAD binding)",NA,NA,NA,"yes"
"82","Hormones/growth factors","ENSBTAG00000047604","hormone reaction"," estrogen activation and androgen inactivation and plays a major role in establishing the estrogen E2 concentration gradient between serum and peripheral tissues","","HSD17B1","hydroxysteroid 17-beta dehydrogenase 1 ",1907.9,10.9,0,0,"up","GO:0004303(estradiol 17-beta-dehydrogenase activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006703(estrogen biosynthetic process);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)","00140(Steroid hormone biosynthesis);04913(Ovarian steroidogenesis)","K00044","EC:1.1.1.62","yes"
"83","Hormones/growth factors","ENSBTAG00000033096","coexist with hormone","family of glyco- proteins produced by binucleate cells of the ruminant placenta","","PAG2","pregnancy-associated glycoprotein 2 ",1547.19,10.6,0.02,0.06,"up","GO:0004190(aspartic-type endopeptidase activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0016787(hydrolase activity);GO:0030163(protein catabolic process)","04974(Protein digestion and absorption)","K06002","EC:3.4.23.1","yes"
"84","Hormones/growth factors","ENSBTAG00000001687","hypocalcemic hormone","cellular calcium/phosphate homeostasis","","STC1","stanniocalcin 1 ",55.23,5.79,0,0,"up","GO:0001886(endothelial cell morphogenesis);GO:0003421(growth plate cartilage axis specification);GO:0005179(hormone activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006874(cellular calcium ion homeostasis);GO:0010469(regulation of signaling receptor activity);GO:0010596(negative regulation of endothelial cell migration);GO:0030336(negative regulation of cell migration);GO:0035988(chondrocyte proliferation);GO:0044070(regulation of anion transport);GO:0051926(negative regulation of calcium ion transport);GO:0060348(bone development);GO:0086004(regulation of cardiac muscle cell contraction);GO:0090280(positive regulation of calcium ion import);GO:1903403(negative regulation of renal phosphate excretion)",NA,NA,NA,"yes"
"85","Hormones/growth factors","ENSBTAG00000001823","hypocalcemic hormone"," calcium and phosphate homeostasis.","","STC2","stanniocalcin 2 ",5.73,2.52,0,0,"up","GO:0005179(hormone activity);GO:0005576(extracellular region);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0006874(cellular calcium ion homeostasis);GO:0006979(response to oxidative stress);GO:0010469(regulation of signaling receptor activity);GO:0010629(negative regulation of gene expression);GO:0019899(enzyme binding);GO:0020037(heme binding);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0034976(response to endoplasmic reticulum stress);GO:0040015(negative regulation of multicellular organism growth);GO:0042803(protein homodimerization activity);GO:0046885(regulation of hormone biosynthetic process);GO:0048471(perinuclear region of cytoplasm);GO:0055074(calcium ion homeostasis);GO:2001256(regulation of store-operated calcium entry)",NA,NA,NA,"yes"
"86","Hormones/growth factors","ENSBTAG00000019453","redox/hormone"," glutathione-dependent prostaglandin E synthase","","PTGES","prostaglandin E synthase ",13.31,3.73,0,0,"up","GO:0001516(prostaglandin biosynthetic process);GO:0004364(glutathione transferase activity);GO:0005641(nuclear envelope lumen);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0006629(lipid metabolic process);GO:0006631(fatty acid metabolic process);GO:0006633(fatty acid biosynthetic process);GO:0006693(prostaglandin metabolic process);GO:0006749(glutathione metabolic process);GO:0008285(negative regulation of cell population proliferation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016853(isomerase activity);GO:0043295(glutathione binding);GO:0050220(prostaglandin-E synthase activity);GO:0055114(oxidation-reduction process);GO:0071347(cellular response to interleukin-1)","00590(Arachidonic acid metabolism)","K15729","EC:5.3.99.3","yes"
"87","Hormones/growth factors","ENSBTAG00000016218","hormone","catalyzes the conversion of prostaglandin H2 to prostaglandin E2","","PTGES2","prostaglandin E synthase 2 ",0.47,-1.09,0,0,"down","GO:0000139(Golgi membrane);GO:0001516(prostaglandin biosynthetic process);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0006629(lipid metabolic process);GO:0006631(fatty acid metabolic process);GO:0006633(fatty acid biosynthetic process);GO:0006693(prostaglandin metabolic process);GO:0009055(electron transfer activity);GO:0015035(protein disulfide oxidoreductase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016829(lyase activity);GO:0016853(isomerase activity);GO:0020037(heme binding);GO:0022900(electron transport chain);GO:0043295(glutathione binding);GO:0045454(cell redox homeostasis);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046903(secretion);GO:0050220(prostaglandin-E synthase activity);GO:0055114(oxidation-reduction process);GO:0055114(oxidation-reduction process)","00590(Arachidonic acid metabolism);00590(Arachidonic acid metabolism)","K05309","EC:5.3.99.3","yes"
"89","Hormones/growth factors","ENSBTAG00000014127","hormone","catalyze the rate-limiting step of prostaglandin production","","PTGS2","prostaglandin-endoperoxide synthase 2 ",2.63,1.39,0,0,"up","GO:0000212(meiotic spindle organization);GO:0001516(prostaglandin biosynthetic process);GO:0001550(ovarian cumulus expansion);GO:0001934(positive regulation of protein phosphorylation);GO:0004601(peroxidase activity);GO:0004666(prostaglandin-endoperoxide synthase activity);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0006954(inflammatory response);GO:0006979(response to oxidative stress);GO:0007566(embryo implantation);GO:0008217(regulation of blood pressure);GO:0019371(cyclooxygenase pathway);GO:0019899(enzyme binding);GO:0020037(heme binding);GO:0031394(positive regulation of prostaglandin biosynthetic process);GO:0031622(positive regulation of fever generation);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0040019(positive regulation of embryonic development);GO:0042127(regulation of cell population proliferation);GO:0042803(protein homodimerization activity);GO:0043005(neuron projection);GO:0043066(negative regulation of apoptotic process);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0046697(decidualization);GO:0050873(brown fat cell differentiation);GO:0055114(oxidation-reduction process);GO:0071347(cellular response to interleukin-1);GO:0071456(cellular response to hypoxia);GO:0071471(cellular response to non-ionic osmotic stress);GO:0071498(cellular response to fluid shear stress);GO:0090336(positive regulation of brown fat cell differentiation);GO:0098869(cellular oxidant detoxification);GO:0150077(regulation of neuroinflammatory response);GO:1900195(positive regulation of oocyte maturation);GO:1902219(negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress);GO:1904146(positive regulation of meiotic cell cycle process involved in oocyte maturation)","00590(Arachidonic acid metabolism);04064(NF-kappa B signaling pathway);04370(VEGF signaling pathway);04625(C-type lectin receptor signaling pathway);04657(IL-17 signaling pathway);04668(TNF signaling pathway);04723(Retrograde endocannabinoid signaling);04726(Serotonergic synapse);04913(Ovarian steroidogenesis);04921(Oxytocin signaling pathway);04923(Regulation of lipolysis in adipocytes);05140(Leishmaniasis);05163(Human cytomegalovirus infection);05165(Human papillomavirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05200(Pathways in cancer);05204(Chemical carcinogenesis);05206(MicroRNAs in cancer);05222(Small cell lung cancer)","K11987","EC:1.14.99.1","yes"
"90","Hormones/growth factors","ENSBTAG00000001335","Growth Hormone","","","GHR","growth hormone receptor ",2.26,1.18,0.01,0.03,"up","GO:0004896(cytokine receptor activity);GO:0004903(growth hormone receptor activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0009897(external side of plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0017046(peptide hormone binding);GO:0019221(cytokine-mediated signaling pathway);GO:0019838(growth factor binding);GO:0019955(cytokine binding);GO:0036464(cytoplasmic ribonucleoprotein granule);GO:0043235(receptor complex);GO:0046427(positive regulation of receptor signaling pathway via JAK-STAT);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0060396(growth hormone receptor signaling pathway);GO:0070195(growth hormone receptor complex)","04060(Cytokine-cytokine receptor interaction);04080(Neuroactive ligand-receptor interaction);04151(PI3K-Akt signaling pathway);04630(Jak-STAT signaling pathway)","K05080",NA,"yes"
"91","Hormones/growth factors","ENSBTAG00000007164","growth factor","","","FGFR3","fibroblast growth factor receptor 3 ",2.76,1.46,0,0,"up","GO:0000165(MAPK cascade);GO:0000166(nucleotide binding);GO:0002009(morphogenesis of an epithelium);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0005007(fibroblast growth factor-activated receptor activity);GO:0005524(ATP binding);GO:0005764(lysosome);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007267(cell-cell signaling);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0009898(cytoplasmic side of plasma membrane);GO:0010518(positive regulation of phospholipase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0017134(fibroblast growth factor binding);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0030133(transport vesicle);GO:0030900(forebrain development);GO:0031398(positive regulation of protein ubiquitination);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0042802(identical protein binding);GO:0043065(positive regulation of apoptotic process);GO:0043235(receptor complex);GO:0043410(positive regulation of MAPK cascade);GO:0043552(positive regulation of phosphatidylinositol 3-kinase activity);GO:0045597(positive regulation of cell differentiation);GO:0046777(protein autophosphorylation);GO:0048471(perinuclear region of cytoplasm);GO:0048839(inner ear development);GO:0050680(negative regulation of epithelial cell proliferation);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0060113(inner ear receptor cell differentiation);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:1902178(fibroblast growth factor receptor apoptotic signaling pathway);GO:1902178(fibroblast growth factor receptor apoptotic signaling pathway)","01521(EGFR tyrosine kinase inhibitor resistance);04010(MAPK signaling pathway);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04144(Endocytosis);04151(PI3K-Akt signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04810(Regulation of actin cytoskeleton);05200(Pathways in cancer);05206(MicroRNAs in cancer);05219(Bladder cancer);05230(Central carbon metabolism in cancer);05230(Central carbon metabolism in cancer)","K05094","EC:2.7.10.1","yes"
"93","Hormones/growth factors","ENSBTAG00000000397","growth factor signaling"," FGF signaling","","CNPY1","canopy FGF signaling regulator 1 ",1033.64,10.01,0.03,0.08,"up","GO:0005783(endoplasmic reticulum);GO:0005783(endoplasmic reticulum)",NA,"K22936",NA,"yes"
"94","Hormones/growth factors","ENSBTAG00000013688","Growth Factor","","","PGF","placental growth factor ",25.63,4.68,0,0,"up","GO:0001525(angiogenesis);GO:0001658(branching involved in ureteric bud morphogenesis);GO:0001666(response to hypoxia);GO:0001934(positive regulation of protein phosphorylation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0002040(sprouting angiogenesis);GO:0005172(vascular endothelial growth factor receptor binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0007275(multicellular organism development);GO:0008083(growth factor activity);GO:0008284(positive regulation of cell population proliferation);GO:0010469(regulation of signaling receptor activity);GO:0016020(membrane);GO:0030154(cell differentiation);GO:0038084(vascular endothelial growth factor signaling pathway);GO:0042056(chemoattractant activity);GO:0045766(positive regulation of angiogenesis);GO:0048010(vascular endothelial growth factor receptor signaling pathway);GO:0050918(positive chemotaxis);GO:0050930(induction of positive chemotaxis);GO:0051781(positive regulation of cell division);GO:0060688(regulation of morphogenesis of a branching structure);GO:0060754(positive regulation of mast cell chemotaxis);GO:0060754(positive regulation of mast cell chemotaxis)","04010(MAPK signaling pathway);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04151(PI3K-Akt signaling pathway);04510(Focal adhesion);05200(Pathways in cancer);05200(Pathways in cancer)","K16859",NA,"yes"
"95","Hormones/growth factors","ENSBTAG00000000027","Growth Factor","","","IGFL1","IGF like family member 1 ",5.87,2.55,0,0,"up","GO:0005102(signaling receptor binding);GO:0005615(extracellular space)",NA,NA,NA,"yes"
"96","Hormones/growth factors","ENSBTAG00000033299","Growth Factor","","","IGFALS","insulin like growth factor binding protein acid labile subunit ",3.04,1.6,0,0,"up","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0042567(insulin-like growth factor ternary complex)",NA,"K17256",NA,"yes"
"97","Hormones/growth factors","ENSBTAG00000005596","Growth Factor","","","IGFBP2","insulin like growth factor binding protein 2 ",3.23,1.69,0,0,"up","GO:0005520(insulin-like growth factor binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0019838(growth factor binding);GO:0031994(insulin-like growth factor I binding);GO:0031995(insulin-like growth factor II binding);GO:0032868(response to insulin);GO:0040008(regulation of growth);GO:0042104(positive regulation of activated T cell proliferation);GO:0043567(regulation of insulin-like growth factor receptor signaling pathway)",NA,NA,NA,"yes"
"98","Hormones/growth factors","ENSBTAG00000021467","Growth Factor","","","IGFBP6","insulin like growth factor binding protein 6 ",2.24,1.17,0,0,"up","GO:0001968(fibronectin binding);GO:0005520(insulin-like growth factor binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0031994(insulin-like growth factor I binding);GO:0031995(insulin-like growth factor II binding);GO:0042568(insulin-like growth factor binary complex);GO:0043567(regulation of insulin-like growth factor receptor signaling pathway)",NA,NA,NA,"yes"
"99","Hormones/growth factors","ENSBTAG00000003994","Growth Factor","","","IGFBP3","insulin like growth factor binding protein 3 ",2.02,1.01,0,0,"up","GO:0001558(regulation of cell growth);GO:0001649(osteoblast differentiation);GO:0001933(negative regulation of protein phosphorylation);GO:0001968(fibronectin binding);GO:0005520(insulin-like growth factor binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0006468(protein phosphorylation);GO:0008160(protein tyrosine phosphatase activator activity);GO:0008285(negative regulation of cell population proliferation);GO:0010906(regulation of glucose metabolic process);GO:0014912(negative regulation of smooth muscle cell migration);GO:0019838(growth factor binding);GO:0031994(insulin-like growth factor I binding);GO:0031995(insulin-like growth factor II binding);GO:0032868(response to insulin);GO:0040008(regulation of growth);GO:0042567(insulin-like growth factor ternary complex);GO:0043065(positive regulation of apoptotic process);GO:0043410(positive regulation of MAPK cascade);GO:0043567(regulation of insulin-like growth factor receptor signaling pathway);GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway);GO:0043666(regulation of phosphoprotein phosphatase activity);GO:0044342(type B pancreatic cell proliferation);GO:0045663(positive regulation of myoblast differentiation);GO:0048662(negative regulation of smooth muscle cell proliferation)","04115(p53 signaling pathway);04218(Cellular senescence);05202(Transcriptional misregulation in cancer)","K10138",NA,"yes"
"100","Hormones/growth factors","ENSBTAG00000009513","Growth Factor","","","TGFBI","transforming growth factor beta induced ",2,1,0,0,"up","GO:0001525(angiogenesis);GO:0005178(integrin binding);GO:0005515(protein binding);GO:0005518(collagen binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005802(trans-Golgi network);GO:0007155(cell adhesion);GO:0008283(cell population proliferation);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix);GO:0050839(cell adhesion molecule binding);GO:0050840(extracellular matrix binding)",NA,"K19519",NA,"yes"
"101","Hormones/growth factors","ENSBTAG00000051898","growth factor","","","FGF7","fibroblast growth factor 7 ",0.32,-1.66,0.02,0.06,"down","GO:0005104(fibroblast growth factor receptor binding);GO:0005576(extracellular region);GO:0005794(Golgi apparatus);GO:0008083(growth factor activity);GO:0008284(positive regulation of cell population proliferation);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0010463(mesenchymal cell proliferation);GO:0010469(regulation of signaling receptor activity);GO:0010838(positive regulation of keratinocyte proliferation);GO:0031069(hair follicle morphogenesis);GO:0031532(actin cytoskeleton reorganization);GO:0034394(protein localization to cell surface);GO:0042056(chemoattractant activity);GO:0045893(positive regulation of transcription, DNA-templated);GO:0050679(positive regulation of epithelial cell proliferation);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050918(positive chemotaxis);GO:0051549(positive regulation of keratinocyte migration);GO:0060445(branching involved in salivary gland morphogenesis);GO:0060501(positive regulation of epithelial cell proliferation involved in lung morphogenesis);GO:0060665(regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling);GO:0061033(secretion by lung epithelial cell involved in lung growth)","04010(MAPK signaling pathway);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04151(PI3K-Akt signaling pathway);04810(Regulation of actin cytoskeleton);05200(Pathways in cancer);05218(Melanoma);05224(Breast cancer);05226(Gastric cancer)","K04358",NA,"yes"
"102","Hormones/growth factors","ENSBTAG00000005162","growth factor ","endosomal trafficking of the epidermal growth factor receptor","","STX19","syntaxin 19 ",0.31,-1.69,0.04,0.09,"down","GO:0000149(SNARE binding);GO:0005484(SNAP receptor activity);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006886(intracellular protein transport);GO:0006887(exocytosis);GO:0006906(vesicle fusion);GO:0008021(synaptic vesicle);GO:0012505(endomembrane system);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016192(vesicle-mediated transport);GO:0031201(SNARE complex);GO:0031629(synaptic vesicle fusion to presynaptic active zone membrane);GO:0042734(presynaptic membrane);GO:0048278(vesicle docking);GO:0048787(presynaptic active zone membrane)","04130(SNARE interactions in vesicular transport)","K08487",NA,"yes"
"107","Protein synthesis/modifications","ENSBTAG00000039285","protein  modification","use dephosphorylated casein as substrate 10.1016/0167-4838(82)90498-8. The permeability characteristics of the Golgi membrane to ATP and Ca2+ therefore have a possible regulatory influence on casein kinase activity.doi: 10.1042/bj2190181.. https://doi.org/10.1046/j.1432-1033.2003.03755.x","CK1","ENSBTAG00000039285","casein kinase I ",1186.58,10.21,0,0,"up","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation)","04310(Wnt signaling pathway);04340(Hedgehog signaling pathway);05165(Human papillomavirus infection);05224(Breast cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer)","K08957","EC:2.7.11.1","yes"
"108","Protein synthesis/modifications","ENSBTAG00000017948","transcription elongation/protein modification"," transcriptional repressor/forming ubiquination substrate complex","","SPIN4","spindlin family member 4 ",804.82,9.65,0.04,0.1,"up","GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0007276(gamete generation);GO:0035064(methylated histone binding)",NA,NA,NA,"yes"
"109","Protein synthesis/modifications","ENSBTAG00000009444","protein transport","Proton oligopeptide cotransporter","","SLC15A5","solute carrier family 15 member 5 ",387.52,8.6,0.01,0.04,"up","GO:0015333(peptide:proton symporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0035672(oligopeptide transmembrane transport);GO:0035673(oligopeptide transmembrane transporter activity);GO:0042886(amide transport);GO:0055085(transmembrane transport);GO:1902600(proton transmembrane transport);GO:1904680(peptide transmembrane transporter activity)",NA,"K14639",NA,"yes"
"110","Protein synthesis/modifications","ENSBTAG00000005337","Protein transport.","","","RAB3B","RAB3B, member RAS oncogene family ",2.2,1.14,0,0.01,"up","GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0006886(intracellular protein transport);GO:0006904(vesicle docking involved in exocytosis);GO:0008021(synaptic vesicle);GO:0009306(protein secretion);GO:0015031(protein transport);GO:0016020(membrane);GO:0017157(regulation of exocytosis);GO:0018125(peptidyl-cysteine methylation);GO:0019003(GDP binding);GO:0019882(antigen processing and presentation);GO:0030141(secretory granule);GO:0030742(GTP-dependent protein binding);GO:0031489(myosin V binding);GO:0031982(vesicle);GO:0032482(Rab protein signal transduction);GO:0048471(perinuclear region of cytoplasm);GO:0051586(positive regulation of dopamine uptake involved in synaptic transmission);GO:0072659(protein localization to plasma membrane);GO:0097494(regulation of vesicle size);GO:0098691(dopaminergic synapse);GO:0098693(regulation of synaptic vesicle cycle);GO:0098993(anchored component of synaptic vesicle membrane)",NA,"K06108",NA,"yes"
"111","Protein synthesis/modifications","ENSBTAG00000021378","protein transport"," the export of proteins that lack a signal peptide","","S100A13","S100 calcium binding protein A13 ",2.13,1.09,0,0,"up","GO:0005507(copper ion binding);GO:0005509(calcium ion binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0008144(drug binding);GO:0008270(zinc ion binding);GO:0008289(lipid binding);GO:0015031(protein transport);GO:0017134(fibroblast growth factor binding);GO:0042629(mast cell granule);GO:0042803(protein homodimerization activity);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043303(mast cell degranulation);GO:0046872(metal ion binding);GO:0048471(perinuclear region of cytoplasm);GO:0050663(cytokine secretion);GO:0050703(interleukin-1 alpha secretion);GO:0050786(RAGE receptor binding);GO:0050786(RAGE receptor binding)",NA,NA,NA,"yes"
"115","Signaling","ENSBTAG00000011224","HIF-1 signaling","nhibits transactivation of HIF1A-induced genes by competing with binding of hypoxia-inducible factor 1-alpha to p300-CH1.","","CITED2","Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2 ",2.21,1.14,0,0,"up","GO:0000790(nuclear chromatin);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0001568(blood vessel development);GO:0001570(vasculogenesis);GO:0001666(response to hypoxia);GO:0001701(in utero embryonic development);GO:0001829(trophectodermal cell differentiation);GO:0001841(neural tube formation);GO:0001843(neural tube closure);GO:0001889(liver development);GO:0001892(embryonic placenta development);GO:0001944(vasculature development);GO:0001947(heart looping);GO:0002089(lens morphogenesis in camera-type eye);GO:0002244(hematopoietic progenitor cell differentiation);GO:0002521(leukocyte differentiation);GO:0003151(outflow tract morphogenesis);GO:0003156(regulation of animal organ formation);GO:0003197(endocardial cushion development);GO:0003281(ventricular septum development);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0003713(transcription coactivator activity);GO:0003714(transcription corepressor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007275(multicellular organism development);GO:0007368(determination of left/right symmetry);GO:0007417(central nervous system development);GO:0007422(peripheral nervous system development);GO:0007507(heart development);GO:0007530(sex determination);GO:0008584(male gonad development);GO:0021602(cranial nerve morphogenesis);GO:0022409(positive regulation of cell-cell adhesion);GO:0030154(cell differentiation);GO:0030325(adrenal gland development);GO:0030511(positive regulation of transforming growth factor beta receptor signaling pathway);GO:0030851(granulocyte differentiation);GO:0035360(positive regulation of peroxisome proliferator activated receptor signaling pathway);GO:0035802(adrenal cortex formation);GO:0035914(skeletal muscle cell differentiation);GO:0043066(negative regulation of apoptotic process);GO:0043627(response to estrogen);GO:0045787(positive regulation of cell cycle);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046332(SMAD binding);GO:0046697(decidualization);GO:0048536(spleen development);GO:0048538(thymus development);GO:0048596(embryonic camera-type eye morphogenesis);GO:0048821(erythrocyte development);GO:0060136(embryonic process involved in female pregnancy);GO:0060349(bone morphogenesis);GO:0060411(cardiac septum morphogenesis);GO:0060412(ventricular septum morphogenesis);GO:0060971(embryonic heart tube left/right pattern formation);GO:0061156(pulmonary artery morphogenesis);GO:0061308(cardiac neural crest cell development involved in heart development);GO:0061371(determination of heart left/right asymmetry);GO:0070986(left/right axis specification);GO:1900164(nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry);GO:1903507(negative regulation of nucleic acid-templated transcription);GO:2000020(positive regulation of male gonad development)","04137(Mitophagy - animal)","K21361",NA,"yes"
"119","Cell structure/proliferation","ENSBTAG00000000951","cell structure/ dynamic processes","microtubule binding activity","Golgi apparatus","JAKMIP3","Janus kinase and microtubule interacting protein 3 ",833.41,9.7,0,0,"up","GO:0008017(microtubule binding);GO:0019900(kinase binding);GO:0019900(kinase binding)",NA,NA,NA,"yes"
"120","Cell structure/proliferation","ENSBTAG00000014207","cell structure","ADAMTS10 is required for focal adhesions, epithelial cell-cell junction formation, and microfibril deposition","","ADAMTS10","ADAM metallopeptidase with thrombospondin type 1 motif 10 ",183.64,7.52,0.01,0.02,"up","GO:0004222(metalloendopeptidase activity);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity)",NA,"K08625","EC:3.4.24.-","yes"
"121","Cell structure/proliferation","ENSBTAG00000040398","cell structure","Involved in epithelial cell integrity by acting on the maintenance of the actin cytoskeleton. Positively regulates the actin polymerization, by inhibiting the interaction of actin-capping proteins with actin","","KIAA1211","KIAA1211 ortholog ",180.84,7.5,0,0.01,"up",NA,NA,NA,NA,"yes"
"125","immune function","ENSBTAG00000053497","immune","Antimicrobial protein that kills intracellular pathogens.","","GNLY","antimicrobial peptide NK-lysin-like ",2499.36,11.29,0,0,"up","GO:0006968(cellular defense response);GO:0042742(defense response to bacterium);GO:0042742(defense response to bacterium)",NA,NA,NA,"yes"
"126","immune function","ENSBTAG00000015635","immune","","","TNFRSF4","TNF receptor superfamily member 4 ",700.77,9.45,0.03,0.07,"up","GO:0005031(tumor necrosis factor-activated receptor activity);GO:0005515(protein binding);GO:0006954(inflammatory response);GO:0006968(cellular defense response);GO:0009897(external side of plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030890(positive regulation of B cell proliferation);GO:0033209(tumor necrosis factor-mediated signaling pathway);GO:0042098(T cell proliferation);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0045859(regulation of protein kinase activity);GO:0045892(negative regulation of transcription, DNA-templated);GO:0050710(negative regulation of cytokine secretion);GO:0051024(positive regulation of immunoglobulin secretion);GO:0070236(negative regulation of activation-induced cell death of T cells);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","04060(Cytokine-cytokine receptor interaction)","K05142",NA,"yes"
"127","immune function","ENSBTAG00000017060","immune response","defects in this gene cause leukocyte adhesion deficiency","","ITGB2","integrin subunit beta 2 ",417.67,8.71,0,0,"up","GO:0001540(amyloid-beta binding);GO:0005178(integrin binding);GO:0005515(protein binding);GO:0005925(focal adhesion);GO:0006909(phagocytosis);GO:0007155(cell adhesion);GO:0007159(leukocyte cell-cell adhesion);GO:0007160(cell-matrix adhesion);GO:0007229(integrin-mediated signaling pathway);GO:0008305(integrin complex);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016477(cell migration);GO:0019901(protein kinase binding);GO:0030369(ICAM-3 receptor activity);GO:0030593(neutrophil chemotaxis);GO:0031072(heat shock protein binding);GO:0031623(receptor internalization);GO:0032930(positive regulation of superoxide anion generation);GO:0033627(cell adhesion mediated by integrin);GO:0034113(heterotypic cell-cell adhesion);GO:0034687(integrin alphaL-beta2 complex);GO:0035987(endodermal cell differentiation);GO:0038023(signaling receptor activity);GO:0043113(receptor clustering);GO:0043235(receptor complex);GO:0043315(positive regulation of neutrophil degranulation);GO:0044853(plasma membrane raft);GO:0046872(metal ion binding);GO:0050730(regulation of peptidyl-tyrosine phosphorylation);GO:0050839(cell adhesion molecule binding);GO:0071404(cellular response to low-density lipoprotein particle stimulus);GO:0099568(cytoplasmic region);GO:1990266(neutrophil migration)","04015(Rap1 signaling pathway);04145(Phagosome);04390(Hippo signaling pathway);04514(Cell adhesion molecules (CAMs));04610(Complement and coagulation cascades);04650(Natural killer cell mediated cytotoxicity);04670(Leukocyte transendothelial migration);04810(Regulation of actin cytoskeleton);05133(Pertussis);05134(Legionellosis);05140(Leishmaniasis);05144(Malaria);05146(Amoebiasis);05150(Staphylococcus aureus infection);05152(Tuberculosis);05166(Human T-cell leukemia virus 1 infection);05323(Rheumatoid arthritis);05416(Viral myocarditis)","K06464",NA,"yes"
"128","immune function","ENSBTAG00000054461","immune"," It mediates cell-cell interaction during inflammatory responses","ITGAX ","ENSBTAG00000054461","integrin subunit alpha X ",259.91,8.02,0,0.01,"up","GO:0007155(cell adhesion);GO:0008305(integrin complex)","04610(Complement and coagulation cascades);04810(Regulation of actin cytoskeleton);05152(Tuberculosis)","K06462",NA,"yes"
"129","immune function","ENSBTAG00000004840","immune","","","C1S","complement C1s ",210.89,7.72,0.01,0.04,"up","GO:0004252(serine-type endopeptidase activity);GO:0005509(calcium ion binding);GO:0005615(extracellular space);GO:0006508(proteolysis);GO:0006958(complement activation, classical pathway);GO:0008233(peptidase activity);GO:0016787(hydrolase activity);GO:0042802(identical protein binding);GO:0042802(identical protein binding)","04610(Complement and coagulation cascades);05133(Pertussis);05150(Staphylococcus aureus infection);05322(Systemic lupus erythematosus);05322(Systemic lupus erythematosus)","K01331","EC:3.4.21.42","yes"
"130","immune function","ENSBTAG00000053635","immune","activation of immune response; defense response to other organism; and phagocytosis","IGHV4-59","ENSBTAG00000053635","immunoglobulin heavy variable 4-59 ",4.45,2.15,0,0,"up",NA,"04020(Calcium signaling pathway);04064(NF-kappa B signaling pathway);04072(Phospholipase D signaling pathway);04145(Phagosome);04151(PI3K-Akt signaling pathway);04640(Hematopoietic cell lineage);04650(Natural killer cell mediated cytotoxicity);04662(B cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04666(Fc gamma R-mediated phagocytosis);04672(Intestinal immune network for IgA production);05140(Leishmaniasis);05143(African trypanosomiasis);05146(Amoebiasis);05150(Staphylococcus aureus infection);05152(Tuberculosis);05169(Epstein-Barr virus infection);05202(Transcriptional misregulation in cancer);05310(Asthma);05320(Autoimmune thyroid disease);05322(Systemic lupus erythematosus);05323(Rheumatoid arthritis);05330(Allograft rejection);05340(Primary immunodeficiency);05414(Dilated cardiomyopathy (DCM));05416(Viral myocarditis)","K06856",NA,"yes"
"131","immune function","ENSBTAG00000014224","immune response","","","IGSF9B","immunoglobulin superfamily member 9B ",4.21,2.07,0,0.01,"up","GO:0005515(protein binding);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019900(kinase binding);GO:0030425(dendrite);GO:0043025(neuronal cell body);GO:0060077(inhibitory synapse);GO:0097151(positive regulation of inhibitory postsynaptic potential);GO:0098982(GABA-ergic synapse);GO:0099560(synaptic membrane adhesion);GO:0099560(synaptic membrane adhesion)",NA,"K22656",NA,"yes"
"132","immune function","ENSBTAG00000019796","immune","May play a role in the immune system processes.","","FCMR","Fc fragment of IgM receptor ",2.37,1.24,0,0,"up","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016021(integral component of membrane)",NA,NA,NA,"yes"
"133","immune function","ENSBTAG00000018869","immune response","","","IGSF6","immunoglobulin superfamily member 6 ",2.33,1.22,0.02,0.04,"up","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016021(integral component of membrane)",NA,NA,NA,"yes"
"134","immune function","ENSBTAG00000001945","immune/oxidative stress",""," mitochondria","ARG2","arginase 2 ",0.47,-1.07,0,0,"down","GO:0000050(urea cycle);GO:0001657(ureteric bud development);GO:0002829(negative regulation of type 2 immune response);GO:0004053(arginase activity);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0006525(arginine metabolic process);GO:0006941(striated muscle contraction);GO:0016787(hydrolase activity);GO:0016813(hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines);GO:0019547(arginine catabolic process to ornithine);GO:0030145(manganese ion binding);GO:0032720(negative regulation of tumor necrosis factor production);GO:0046872(metal ion binding);GO:0050706(regulation of interleukin-1 beta secretion);GO:0071641(negative regulation of macrophage inflammatory protein 1 alpha production);GO:0071644(negative regulation of chemokine (C-C motif) ligand 4 production);GO:0071650(negative regulation of chemokine (C-C motif) ligand 5 production);GO:1900425(negative regulation of defense response to bacterium);GO:1903426(regulation of reactive oxygen species biosynthetic process);GO:1904468(negative regulation of tumor necrosis factor secretion);GO:1905077(negative regulation of interleukin-17 secretion);GO:1905403(negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process);GO:2000562(negative regulation of CD4-positive, alpha-beta T cell proliferation);GO:2000666(negative regulation of interleukin-13 secretion);GO:2000774(positive regulation of cellular senescence);GO:2000774(positive regulation of cellular senescence)","00220(Arginine biosynthesis);00330(Arginine and proline metabolism);05146(Amoebiasis);05146(Amoebiasis)","K01476","EC:3.5.3.1","yes"
"135","immune function","ENSBTAG00000008008","immune","","","TLR2","toll like receptor 2 ",0.31,-1.7,0,0,"down","GO:0001530(lipopolysaccharide binding);GO:0001540(amyloid-beta binding);GO:0001775(cell activation);GO:0002224(toll-like receptor signaling pathway);GO:0002237(response to molecule of bacterial origin);GO:0002374(cytokine secretion involved in immune response);GO:0002376(immune system process);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006954(inflammatory response);GO:0007165(signal transduction);GO:0007252(I-kappaB phosphorylation);GO:0008329(signaling pattern recognition receptor activity);GO:0009986(cell surface);GO:0010628(positive regulation of gene expression);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030177(positive regulation of Wnt signaling pathway);GO:0031226(intrinsic component of plasma membrane);GO:0032613(interleukin-10 production);GO:0032722(positive regulation of chemokine production);GO:0032755(positive regulation of interleukin-6 production);GO:0032757(positive regulation of interleukin-8 production);GO:0034123(positive regulation of toll-like receptor signaling pathway);GO:0034134(toll-like receptor 2 signaling pathway);GO:0035325(Toll-like receptor binding);GO:0035354(Toll-like receptor 1-Toll-like receptor 2 protein complex);GO:0042495(detection of triacyl bacterial lipopeptide);GO:0042496(detection of diacyl bacterial lipopeptide);GO:0042497(triacyl lipopeptide binding);GO:0042802(identical protein binding);GO:0042834(peptidoglycan binding);GO:0044877(protein-containing complex binding);GO:0045087(innate immune response);GO:0045121(membrane raft);GO:0046982(protein heterodimerization activity);GO:0050707(regulation of cytokine secretion);GO:0050729(positive regulation of inflammatory response);GO:0050830(defense response to Gram-positive bacterium);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0071223(cellular response to lipoteichoic acid);GO:0071346(cellular response to interferon-gamma);GO:0071726(cellular response to diacyl bacterial lipopeptide);GO:0071727(cellular response to triacyl bacterial lipopeptide);GO:1901224(positive regulation of NIK/NF-kappaB signaling);GO:1903974(positive regulation of cellular response to macrophage colony-stimulating factor stimulus);GO:2000484(positive regulation of interleukin-8 secretion)","04145(Phagosome);04151(PI3K-Akt signaling pathway);04620(Toll-like receptor signaling pathway);05134(Legionellosis);05140(Leishmaniasis);05142(Chagas disease (American trypanosomiasis));05144(Malaria);05145(Toxoplasmosis);05146(Amoebiasis);05152(Tuberculosis);05161(Hepatitis B);05162(Measles);05168(Herpes simplex virus 1 infection);05169(Epstein-Barr virus infection);05170(Human immunodeficiency virus 1 infection);05205(Proteoglycans in cancer);05321(Inflammatory bowel disease (IBD));05323(Rheumatoid arthritis)","K10159",NA,"yes"
"136","immune function","ENSBTAG00000018571","immune response","","","IL1RL1","interleukin 1 receptor like 1 ",0.07,-3.85,0,0.01,"down","GO:0002826(negative regulation of T-helper 1 type immune response);GO:0004908(interleukin-1 receptor activity);GO:0005515(protein binding);GO:0007165(signal transduction);GO:0009897(external side of plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019221(cytokine-mediated signaling pathway);GO:0032689(negative regulation of interferon-gamma production);GO:0032754(positive regulation of interleukin-5 production);GO:0043032(positive regulation of macrophage activation);GO:0050729(positive regulation of inflammatory response);GO:0090197(positive regulation of chemokine secretion);GO:0090197(positive regulation of chemokine secretion)","04060(Cytokine-cytokine receptor interaction);04060(Cytokine-cytokine receptor interaction)","K05171",NA,"yes"
"137","immune function","ENSBTAG00000025471","immune","proinflammatory cytokine","","TNF","tumor necrosis factor ",0,-8.59,0.01,0.02,"down","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000165(MAPK cascade);GO:0000185(activation of MAPKKK activity);GO:0000187(activation of MAPK activity);GO:0001774(microglial cell activation);GO:0001819(positive regulation of cytokine production);GO:0001891(phagocytic cup);GO:0001932(regulation of protein phosphorylation);GO:0001934(positive regulation of protein phosphorylation);GO:0001937(negative regulation of endothelial cell proliferation);GO:0002020(protease binding);GO:0002439(chronic inflammatory response to antigenic stimulus);GO:0002532(production of molecular mediator involved in inflammatory response);GO:0002740(negative regulation of cytokine secretion involved in immune response);GO:0002876(positive regulation of chronic inflammatory response to antigenic stimulus);GO:0002925(positive regulation of humoral immune response mediated by circulating immunoglobulin);GO:0005125(cytokine activity);GO:0005164(tumor necrosis factor receptor binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006006(glucose metabolic process);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0006952(defense response);GO:0006954(inflammatory response);GO:0006955(immune response);GO:0006959(humoral immune response);GO:0007254(JNK cascade);GO:0007275(multicellular organism development);GO:0008625(extrinsic apoptotic signaling pathway via death domain receptors);GO:0008630(intrinsic apoptotic signaling pathway in response to DNA damage);GO:0009615(response to virus);GO:0009887(animal organ morphogenesis);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0010033(response to organic substance);GO:0010469(regulation of signaling receptor activity);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0010693(negative regulation of alkaline phosphatase activity);GO:0010756(positive regulation of plasminogen activation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030198(extracellular matrix organization);GO:0030316(osteoclast differentiation);GO:0030730(sequestering of triglyceride);GO:0030866(cortical actin cytoskeleton organization);GO:0031334(positive regulation of protein complex assembly);GO:0031622(positive regulation of fever generation);GO:0031663(lipopolysaccharide-mediated signaling pathway);GO:0032715(negative regulation of interleukin-6 production);GO:0032722(positive regulation of chemokine production);GO:0032729(positive regulation of interferon-gamma production);GO:0032755(positive regulation of interleukin-6 production);GO:0032757(positive regulation of interleukin-8 production);GO:0032800(receptor biosynthetic process);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0033209(tumor necrosis factor-mediated signaling pathway);GO:0034116(positive regulation of heterotypic cell-cell adhesion);GO:0035509(negative regulation of myosin-light-chain-phosphatase activity);GO:0042127(regulation of cell population proliferation);GO:0042742(defense response to bacterium);GO:0042802(identical protein binding);GO:0043065(positive regulation of apoptotic process);GO:0043068(positive regulation of programmed cell death);GO:0043122(regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043242(negative regulation of protein complex disassembly);GO:0043243(positive regulation of protein complex disassembly);GO:0043280(positive regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043406(positive regulation of MAP kinase activity);GO:0043491(protein kinase B signaling);GO:0043507(positive regulation of JUN kinase activity);GO:0043525(positive regulation of neuron apoptotic process);GO:0044130(negative regulation of growth of symbiont in host);GO:0044212(transcription regulatory region DNA binding);GO:0045071(negative regulation of viral genome replication);GO:0045080(positive regulation of chemokine biosynthetic process);GO:0045121(membrane raft);GO:0045123(cellular extravasation);GO:0045416(positive regulation of interleukin-8 biosynthetic process);GO:0045429(positive regulation of nitric oxide biosynthetic process);GO:0045662(negative regulation of myoblast differentiation);GO:0045668(negative regulation of osteoblast differentiation);GO:0045670(regulation of osteoclast differentiation);GO:0045672(positive regulation of osteoclast differentiation);GO:0045732(positive regulation of protein catabolic process);GO:0045785(positive regulation of cell adhesion);GO:0045860(positive regulation of protein kinase activity);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045930(negative regulation of mitotic cell cycle);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045994(positive regulation of translational initiation by iron);GO:0046325(negative regulation of glucose import);GO:0046330(positive regulation of JNK cascade);GO:0048566(embryonic digestive tract development);GO:0048661(positive regulation of smooth muscle cell proliferation);GO:0050708(regulation of protein secretion);GO:0050715(positive regulation of cytokine secretion);GO:0050727(regulation of inflammatory response);GO:0050729(positive regulation of inflammatory response);GO:0050766(positive regulation of phagocytosis);GO:0050796(regulation of insulin secretion);GO:0050806(positive regulation of synaptic transmission);GO:0050807(regulation of synapse organization);GO:0050830(defense response to Gram-positive bacterium);GO:0050900(leukocyte migration);GO:0050901(leukocyte tethering or rolling);GO:0050995(negative regulation of lipid catabolic process);GO:0051023(regulation of immunoglobulin secretion);GO:0051044(positive regulation of membrane protein ectodomain proteolysis);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051222(positive regulation of protein transport);GO:0051384(response to glucocorticoid);GO:0051798(positive regulation of hair follicle development);GO:0051897(positive regulation of protein kinase B signaling);GO:0055037(recycling endosome);GO:0060252(positive regulation of glial cell proliferation);GO:0060557(positive regulation of vitamin D biosynthetic process);GO:0060559(positive regulation of calcidiol 1-monooxygenase activity);GO:0060664(epithelial cell proliferation involved in salivary gland morphogenesis);GO:0060693(regulation of branching involved in salivary gland morphogenesis);GO:0061048(negative regulation of branching involved in lung morphogenesis);GO:0070886(positive regulation of calcineurin-NFAT signaling cascade);GO:0071222(cellular response to lipopolysaccharide);GO:0071230(cellular response to amino acid stimulus);GO:0071316(cellular response to nicotine);GO:0071407(cellular response to organic cyclic compound);GO:0071803(positive regulation of podosome assembly);GO:0072577(endothelial cell apoptotic process);GO:0072659(protein localization to plasma membrane);GO:0090208(positive regulation of triglyceride metabolic process);GO:0097190(apoptotic signaling pathway);GO:0097191(extrinsic apoptotic signaling pathway);GO:0097527(necroptotic signaling pathway);GO:1901224(positive regulation of NIK/NF-kappaB signaling);GO:1901671(positive regulation of superoxide dismutase activity);GO:1903078(positive regulation of protein localization to plasma membrane);GO:1903140(regulation of establishment of endothelial barrier);GO:1903347(negative regulation of bicellular tight junction assembly);GO:1903488(negative regulation of lactation);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:1904996(positive regulation of leukocyte adhesion to vascular endothelial cell);GO:1904999(positive regulation of leukocyte adhesion to arterial endothelial cell);GO:2000010(positive regulation of protein localization to cell surface);GO:2000252(negative regulation of feeding behavior);GO:2000334(positive regulation of blood microparticle formation);GO:2000343(positive regulation of chemokine (C-X-C motif) ligand 2 production);GO:2000351(regulation of endothelial cell apoptotic process);GO:2000377(regulation of reactive oxygen species metabolic process);GO:2001240(negative regulation of extrinsic apoptotic signaling pathway in absence of ligand)","01523(Antifolate resistance);04010(MAPK signaling pathway);04060(Cytokine-cytokine receptor interaction);04064(NF-kappa B signaling pathway);04071(Sphingolipid signaling pathway);04150(mTOR signaling pathway);04210(Apoptosis);04217(Necroptosis);04350(TGF-beta signaling pathway);04380(Osteoclast differentiation);04612(Antigen processing and presentation);04620(Toll-like receptor signaling pathway);04621(NOD-like receptor signaling pathway);04622(RIG-I-like receptor signaling pathway);04625(C-type lectin receptor signaling pathway);04640(Hematopoietic cell lineage);04650(Natural killer cell mediated cytotoxicity);04657(IL-17 signaling pathway);04660(T cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04668(TNF signaling pathway);04920(Adipocytokine signaling pathway);04930(Type II diabetes mellitus);04931(Insulin resistance);04932(Non-alcoholic fatty liver disease (NAFLD));04933(AGE-RAGE signaling pathway in diabetic complications);04940(Type I diabetes mellitus);05010(Alzheimer disease);05014(Amyotrophic lateral sclerosis (ALS));05133(Pertussis);05134(Legionellosis);05140(Leishmaniasis);05142(Chagas disease (American trypanosomiasis));05143(African trypanosomiasis);05144(Malaria);05145(Toxoplasmosis);05146(Amoebiasis);05152(Tuberculosis);05160(Hepatitis C);05161(Hepatitis B);05163(Human cytomegalovirus infection);05164(Influenza A);05165(Human papillomavirus infection);05166(Human T-cell leukemia virus 1 infection);05168(Herpes simplex virus 1 infection);05169(Epstein-Barr virus infection);05170(Human immunodeficiency virus 1 infection);05205(Proteoglycans in cancer);05310(Asthma);05321(Inflammatory bowel disease (IBD));05322(Systemic lupus erythematosus);05323(Rheumatoid arthritis);05330(Allograft rejection);05332(Graft-versus-host disease);05410(Hypertrophic cardiomyopathy (HCM));05414(Dilated cardiomyopathy (DCM));05418(Fluid shear stress and atherosclerosis)","K03156",NA,"yes"
"138","immune function","ENSBTAG00000007626","immune response","","","IL2RG","interleukin 2 receptor subunit gamma ",0,-8.79,0.02,0.06,"down","GO:0004896(cytokine receptor activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019955(cytokine binding);GO:0019976(interleukin-2 binding);GO:0035723(interleukin-15-mediated signaling pathway);GO:0042010(interleukin-15 receptor activity);GO:0043235(receptor complex);GO:0050766(positive regulation of phagocytosis);GO:0050766(positive regulation of phagocytosis)","04060(Cytokine-cytokine receptor interaction);04144(Endocytosis);04151(PI3K-Akt signaling pathway);04630(Jak-STAT signaling pathway);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);05162(Measles);05166(Human T-cell leukemia virus 1 infection);05200(Pathways in cancer);05321(Inflammatory bowel disease (IBD));05340(Primary immunodeficiency);05340(Primary immunodeficiency)","K05070",NA,"yes"
"139","immune function","ENSBTAG00000040056","inflammation"," potent proinflammatory lipid mediator ","","LTB4R2","leukotriene B4 receptor 2 ",12.54,3.65,0,0,"up","GO:0001632(leukotriene B4 receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0004966(galanin receptor activity);GO:0004974(leukotriene receptor activity);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006954(inflammatory response);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007218(neuropeptide signaling pathway);GO:0008528(G protein-coupled peptide receptor activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0051546(keratinocyte migration);GO:0061737(leukotriene signaling pathway)","04020(Calcium signaling pathway);04080(Neuroactive ligand-receptor interaction)","K04297",NA,"yes"
"140","immune function","ENSBTAG00000006694"," inflammation","involved in immunoregulatory and inflammatory processes","","CXCL14","C-X-C motif chemokine ligand 14 ",2.74,1.45,0,0,"up","GO:0005576(extracellular region);GO:0005794(Golgi apparatus);GO:0006955(immune response);GO:0008009(chemokine activity);GO:0045662(negative regulation of myoblast differentiation);GO:0048839(inner ear development);GO:0060326(cell chemotaxis);GO:2000503(positive regulation of natural killer cell chemotaxis)","04060(Cytokine-cytokine receptor interaction);04062(Chemokine signaling pathway)","K10033",NA,"yes"
"141","immune function","ENSBTAG00000001060"," inflammation","","","CXCR4","C-X-C motif chemokine receptor 4 ",2.4,1.26,0,0,"up","GO:0001666(response to hypoxia);GO:0003779(actin binding);GO:0004930(G protein-coupled receptor activity);GO:0004950(chemokine receptor activity);GO:0005764(lysosome);GO:0005768(endosome);GO:0005769(early endosome);GO:0005770(late endosome);GO:0005886(plasma membrane);GO:0006935(chemotaxis);GO:0006955(immune response);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0007420(brain development);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016493(C-C chemokine receptor activity);GO:0019722(calcium-mediated signaling);GO:0019955(cytokine binding);GO:0019956(chemokine binding);GO:0019957(C-C chemokine binding);GO:0022008(neurogenesis);GO:0030054(cell junction);GO:0030155(regulation of cell adhesion);GO:0031252(cell leading edge);GO:0031410(cytoplasmic vesicle);GO:0031625(ubiquitin protein ligase binding);GO:0032027(myosin light chain binding);GO:0032991(protein-containing complex);GO:0038147(C-X-C motif chemokine 12 receptor activity);GO:0038160(CXCL12-activated CXCR4 signaling pathway);GO:0043130(ubiquitin binding);GO:0050920(regulation of chemotaxis);GO:0060326(cell chemotaxis);GO:0071345(cellular response to cytokine stimulus)","04020(Calcium signaling pathway);04060(Cytokine-cytokine receptor interaction);04062(Chemokine signaling pathway);04144(Endocytosis);04360(Axon guidance);04670(Leukocyte transendothelial migration);04672(Intestinal immune network for IgA production);04810(Regulation of actin cytoskeleton);05163(Human cytomegalovirus infection);05170(Human immunodeficiency virus 1 infection);05200(Pathways in cancer)","K04189",NA,"yes"
"142","immune function","ENSBTAG00000015483","inflammation","Chemokine CC receptors (CCRs) predominantly recognize CC chemokines","","CCR8","C-C motif chemokine receptor 8 ",0.42,-1.24,0.03,0.08,"down","GO:0004930(G protein-coupled receptor activity);GO:0004950(chemokine receptor activity);GO:0006935(chemotaxis);GO:0006955(immune response);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0009897(external side of plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016493(C-C chemokine receptor activity);GO:0019722(calcium-mediated signaling);GO:0019956(chemokine binding);GO:0019957(C-C chemokine binding);GO:0060326(cell chemotaxis);GO:0070098(chemokine-mediated signaling pathway)","04060(Cytokine-cytokine receptor interaction);04062(Chemokine signaling pathway);05167(Kaposi sarcoma-associated herpesvirus infection);05203(Viral carcinogenesis)","K04183",NA,"yes"
"143","immune function","ENSBTAG00000037558","inflammation","","","GRO1","chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) ",0.4,-1.32,0,0,"down","GO:0005125(cytokine activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006935(chemotaxis);GO:0006952(defense response);GO:0006954(inflammatory response);GO:0006955(immune response);GO:0008009(chemokine activity);GO:0008083(growth factor activity);GO:0010469(regulation of signaling receptor activity);GO:0030593(neutrophil chemotaxis);GO:0030595(leukocyte chemotaxis);GO:0061844(antimicrobial humoral immune response mediated by antimicrobial peptide);GO:0070098(chemokine-mediated signaling pathway);GO:0071222(cellular response to lipopolysaccharide)","04060(Cytokine-cytokine receptor interaction);04062(Chemokine signaling pathway);04621(NOD-like receptor signaling pathway);04657(IL-17 signaling pathway);04668(TNF signaling pathway);05132(Salmonella infection);05134(Legionellosis);05167(Kaposi sarcoma-associated herpesvirus infection)","K05505",NA,"yes"
"144","immune function","ENSBTAG00000009812"," inflammation","Involved in neutrophil activation","","CXCL5","chemokine (C-X-C motif) ligand 5 ",0.36,-1.45,0,0,"down","GO:0005125(cytokine activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006935(chemotaxis);GO:0006952(defense response);GO:0006954(inflammatory response);GO:0006955(immune response);GO:0008009(chemokine activity);GO:0008201(heparin binding);GO:0010469(regulation of signaling receptor activity);GO:0030593(neutrophil chemotaxis);GO:0030595(leukocyte chemotaxis);GO:0042119(neutrophil activation);GO:0042742(defense response to bacterium);GO:0061844(antimicrobial humoral immune response mediated by antimicrobial peptide);GO:0070098(chemokine-mediated signaling pathway);GO:0071222(cellular response to lipopolysaccharide)","04060(Cytokine-cytokine receptor interaction);04062(Chemokine signaling pathway);04657(IL-17 signaling pathway);05133(Pertussis);05323(Rheumatoid arthritis)","K05506",NA,"yes"
"145","immune function","ENSBTAG00000021326","inflammation","This antimicrobial gene belongs to the subfamily of small cytokine CC genes","","CCL20","C-C motif chemokine ligand 20 ",0.21,-2.28,0.05,0.11,"down","GO:0002548(monocyte chemotaxis);GO:0005125(cytokine activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006935(chemotaxis);GO:0006954(inflammatory response);GO:0006955(immune response);GO:0007186(G protein-coupled receptor signaling pathway);GO:0008009(chemokine activity);GO:0010469(regulation of signaling receptor activity);GO:0030593(neutrophil chemotaxis);GO:0031731(CCR6 chemokine receptor binding);GO:0035584(calcium-mediated signaling using intracellular calcium source);GO:0043547(positive regulation of GTPase activity);GO:0048020(CCR chemokine receptor binding);GO:0048247(lymphocyte chemotaxis);GO:0060326(cell chemotaxis);GO:0070098(chemokine-mediated signaling pathway);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0071346(cellular response to interferon-gamma);GO:0071347(cellular response to interleukin-1);GO:0071356(cellular response to tumor necrosis factor);GO:0072678(T cell migration);GO:0072679(thymocyte migration);GO:2000406(positive regulation of T cell migration)","04060(Cytokine-cytokine receptor interaction);04062(Chemokine signaling pathway);04657(IL-17 signaling pathway);04668(TNF signaling pathway);05323(Rheumatoid arthritis)","K14625",NA,"yes"
"146","immune function","ENSBTAG00000019716","inflammation","a major mediator of the inflammatory response.","","CXCL8","C-X-C motif chemokine ligand 8 ",0.13,-2.96,0,0.01,"down","GO:0002237(response to molecule of bacterial origin);GO:0005125(cytokine activity);GO:0005153(interleukin-8 receptor binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006935(chemotaxis);GO:0006952(defense response);GO:0006954(inflammatory response);GO:0006955(immune response);GO:0007050(cell cycle arrest);GO:0008009(chemokine activity);GO:0010469(regulation of signaling receptor activity);GO:0030155(regulation of cell adhesion);GO:0030593(neutrophil chemotaxis);GO:0030595(leukocyte chemotaxis);GO:0031623(receptor internalization);GO:0034976(response to endoplasmic reticulum stress);GO:0035556(intracellular signal transduction);GO:0042119(neutrophil activation);GO:0044344(cellular response to fibroblast growth factor stimulus);GO:0045091(regulation of single stranded viral RNA replication via double stranded DNA intermediate);GO:0045744(negative regulation of G protein-coupled receptor signaling pathway);GO:0045766(positive regulation of angiogenesis);GO:0048566(embryonic digestive tract development);GO:0050930(induction of positive chemotaxis);GO:0061844(antimicrobial humoral immune response mediated by antimicrobial peptide);GO:0070098(chemokine-mediated signaling pathway);GO:0071222(cellular response to lipopolysaccharide);GO:0071347(cellular response to interleukin-1);GO:0071356(cellular response to tumor necrosis factor);GO:2000535(regulation of entry of bacterium into host cell)","04060(Cytokine-cytokine receptor interaction);04062(Chemokine signaling pathway);04064(NF-kappa B signaling pathway);04072(Phospholipase D signaling pathway);04218(Cellular senescence);04620(Toll-like receptor signaling pathway);04621(NOD-like receptor signaling pathway);04622(RIG-I-like receptor signaling pathway);04657(IL-17 signaling pathway);04932(Non-alcoholic fatty liver disease (NAFLD));04933(AGE-RAGE signaling pathway in diabetic complications);05132(Salmonella infection);05133(Pertussis);05134(Legionellosis);05142(Chagas disease (American trypanosomiasis));05144(Malaria);05146(Amoebiasis);05161(Hepatitis B);05163(Human cytomegalovirus infection);05164(Influenza A);05167(Kaposi sarcoma-associated herpesvirus infection);05200(Pathways in cancer);05202(Transcriptional misregulation in cancer);05219(Bladder cancer);05323(Rheumatoid arthritis)","K10030",NA,"yes"
"147","immune function","ENSBTAG00000024869","inflammation","","","CX3CL1","C-X3-C motif chemokine ligand 1 ",0.13,-2.96,0,0.01,"down","GO:0002548(monocyte chemotaxis);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006954(inflammatory response);GO:0006955(immune response);GO:0007186(G protein-coupled receptor signaling pathway);GO:0008009(chemokine activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019221(cytokine-mediated signaling pathway);GO:0030593(neutrophil chemotaxis);GO:0043547(positive regulation of GTPase activity);GO:0048020(CCR chemokine receptor binding);GO:0048245(eosinophil chemotaxis);GO:0048247(lymphocyte chemotaxis);GO:0050902(leukocyte adhesive activation);GO:0060326(cell chemotaxis);GO:0070098(chemokine-mediated signaling pathway);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0071346(cellular response to interferon-gamma);GO:0071347(cellular response to interleukin-1);GO:0071356(cellular response to tumor necrosis factor)","04060(Cytokine-cytokine receptor interaction);04062(Chemokine signaling pathway);04668(TNF signaling pathway);05163(Human cytomegalovirus infection)","K05508",NA,"yes"
"151","Others","ENSBTAG00000019453","redox/hormone"," glutathione-dependent prostaglandin E synthase","","PTGES","prostaglandin E synthase ",13.31,3.73,0,0,"up","GO:0001516(prostaglandin biosynthetic process);GO:0004364(glutathione transferase activity);GO:0005641(nuclear envelope lumen);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0006629(lipid metabolic process);GO:0006631(fatty acid metabolic process);GO:0006633(fatty acid biosynthetic process);GO:0006693(prostaglandin metabolic process);GO:0006749(glutathione metabolic process);GO:0008285(negative regulation of cell population proliferation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016853(isomerase activity);GO:0043295(glutathione binding);GO:0050220(prostaglandin-E synthase activity);GO:0055114(oxidation-reduction process);GO:0071347(cellular response to interleukin-1)","00590(Arachidonic acid metabolism)","K15729","EC:5.3.99.3","yes"
"153","Others","ENSBTAG00000017680","redox hemeostasis","","","NOS3","nitric oxide synthase 3 ",4.11,2.04,0,0,"up","GO:0001525(angiogenesis);GO:0001542(ovulation from ovarian follicle);GO:0001701(in utero embryonic development);GO:0001974(blood vessel remodeling);GO:0002028(regulation of sodium ion transport);GO:0003057(regulation of the force of heart contraction by chemical signal);GO:0003100(regulation of systemic arterial blood pressure by endothelin);GO:0003180(aortic valve morphogenesis);GO:0003184(pulmonary valve morphogenesis);GO:0003203(endocardial cushion morphogenesis);GO:0003785(actin monomer binding);GO:0003958(NADPH-hemoprotein reductase activity);GO:0004517(nitric-oxide synthase activity);GO:0005516(calmodulin binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0006527(arginine catabolic process);GO:0006809(nitric oxide biosynthetic process);GO:0007263(nitric oxide mediated signal transduction);GO:0008285(negative regulation of cell population proliferation);GO:0009725(response to hormone);GO:0010181(FMN binding);GO:0010628(positive regulation of gene expression);GO:0012506(vesicle membrane);GO:0014740(negative regulation of muscle hyperplasia);GO:0014806(smooth muscle hyperplasia);GO:0016491(oxidoreductase activity);GO:0019430(removal of superoxide radicals);GO:0020037(heme binding);GO:0030324(lung development);GO:0031284(positive regulation of guanylate cyclase activity);GO:0031644(regulation of neurological system process);GO:0031663(lipopolysaccharide-mediated signaling pathway);GO:0032496(response to lipopolysaccharide);GO:0034405(response to fluid shear stress);GO:0034617(tetrahydrobiopterin binding);GO:0034618(arginine binding);GO:0043267(negative regulation of potassium ion transport);GO:0043536(positive regulation of blood vessel endothelial cell migration);GO:0043542(endothelial cell migration);GO:0045766(positive regulation of angiogenesis);GO:0045776(negative regulation of blood pressure);GO:0046872(metal ion binding);GO:0048873(homeostasis of number of cells within a tissue);GO:0050660(flavin adenine dinucleotide binding);GO:0050661(NADP binding);GO:0050880(regulation of blood vessel size);GO:0051346(negative regulation of hydrolase activity);GO:0051926(negative regulation of calcium ion transport);GO:0055114(oxidation-reduction process);GO:0060412(ventricular septum morphogenesis);GO:0070168(negative regulation of biomineral tissue development);GO:0097110(scaffold protein binding)","00220(Arginine biosynthesis);00330(Arginine and proline metabolism);04020(Calcium signaling pathway);04022(cGMP-PKG signaling pathway);04066(HIF-1 signaling pathway);04071(Sphingolipid signaling pathway);04151(PI3K-Akt signaling pathway);04370(VEGF signaling pathway);04371(Apelin signaling pathway);04611(Platelet activation);04915(Estrogen signaling pathway);04921(Oxytocin signaling pathway);04926(Relaxin signaling pathway);04931(Insulin resistance);04933(AGE-RAGE signaling pathway in diabetic complications);05418(Fluid shear stress and atherosclerosis)","K13242","EC:1.14.13.39","yes"
"157","Energy metabolism","ENSBTAG00000007496","ATP"," response to extracellular ATP","","P2RX2","purinergic receptor P2X 2 ",599.15,9.23,0,0,"up","GO:0001614(purinergic nucleotide receptor activity);GO:0001666(response to hypoxia);GO:0003029(detection of hypoxic conditions in blood by carotid body chemoreceptor signaling);GO:0004931(extracellularly ATP-gated cation channel activity);GO:0005216(ion channel activity);GO:0005524(ATP binding);GO:0005639(integral component of nuclear inner membrane);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006811(ion transport);GO:0006812(cation transport);GO:0007268(chemical synaptic transmission);GO:0007274(neuromuscular synaptic transmission);GO:0007528(neuromuscular junction development);GO:0007605(sensory perception of sound);GO:0009743(response to carbohydrate);GO:0010033(response to organic substance);GO:0014832(urinary bladder smooth muscle contraction);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016324(apical plasma membrane);GO:0030432(peristalsis);GO:0033198(response to ATP);GO:0034220(ion transmembrane transport);GO:0035381(ATP-gated ion channel activity);GO:0035590(purinergic nucleotide receptor signaling pathway);GO:0042802(identical protein binding);GO:0043235(receptor complex);GO:0048266(behavioral response to pain);GO:0048741(skeletal muscle fiber development);GO:0050909(sensory perception of taste);GO:0051260(protein homooligomerization);GO:0060079(excitatory postsynaptic potential);GO:0098655(cation transmembrane transport);GO:0098794(postsynapse)","04020(Calcium signaling pathway);04080(Neuroactive ligand-receptor interaction);04742(Taste transduction)","K05216",NA,"yes"
"158","Energy metabolism","ENSBTAG00000018419","ATP","convert adenosine-5'-triphosphate (ATP) into 3',5'-adenosine monophosphate (cyclic AMP/cAMP) and pyrophosphate","","ADCY4","adenylate cyclase 4 ",3.33,1.74,0,0,"up","GO:0000166(nucleotide binding);GO:0004016(adenylate cyclase activity);GO:0005080(protein kinase C binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006171(cAMP biosynthetic process);GO:0007188(adenylate cyclase-modulating G protein-coupled receptor signaling pathway);GO:0007189(adenylate cyclase-activating G protein-coupled receptor signaling pathway);GO:0009190(cyclic nucleotide biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016829(lyase activity);GO:0016849(phosphorus-oxygen lyase activity);GO:0030425(dendrite);GO:0035556(intracellular signal transduction);GO:0046872(metal ion binding)","00230(Purine metabolism);01522(Endocrine resistance);04015(Rap1 signaling pathway);04020(Calcium signaling pathway);04022(cGMP-PKG signaling pathway);04024(cAMP signaling pathway);04062(Chemokine signaling pathway);04072(Phospholipase D signaling pathway);04114(Oocyte meiosis);04211(Longevity regulating pathway);04213(Longevity regulating pathway - multiple species);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04371(Apelin signaling pathway);04540(Gap junction);04611(Platelet activation);04713(Circadian entrainment);04714(Thermogenesis);04723(Retrograde endocannabinoid signaling);04724(Glutamatergic synapse);04725(Cholinergic synapse);04727(GABAergic synapse);04742(Taste transduction);04750(Inflammatory mediator regulation of TRP channels);04911(Insulin secretion);04912(GnRH signaling pathway);04913(Ovarian steroidogenesis);04914(Progesterone-mediated oocyte maturation);04915(Estrogen signaling pathway);04916(Melanogenesis);04918(Thyroid hormone synthesis);04921(Oxytocin signaling pathway);04923(Regulation of lipolysis in adipocytes);04925(Aldosterone synthesis and secretion);04926(Relaxin signaling pathway);04927(Cortisol synthesis and secretion);04928(Parathyroid hormone synthesis, secretion and action);04934(Cushing syndrome);04970(Salivary secretion);04971(Gastric acid secretion);04972(Pancreatic secretion);04976(Bile secretion);05032(Morphine addiction);05163(Human cytomegalovirus infection);05166(Human T-cell leukemia virus 1 infection);05200(Pathways in cancer);05414(Dilated cardiomyopathy (DCM))","K08044","EC:4.6.1.1","yes"
"160","Energy metabolism","ENSBTAG00000010116","energy","?response to local energy demands, AKs allow the transfer of the two high-energy phosphoryl bonds of ATP from sites where ATP is generated to sites of ATP utilization","","AK9","adenylate kinase 9 ",7.09,2.83,0.01,0.04,"up","GO:0005524(ATP binding);GO:0006139(nucleobase-containing compound metabolic process);GO:0016310(phosphorylation);GO:0019205(nucleobase-containing compound kinase activity)",NA,NA,NA,"yes"
"161","Energy metabolism","ENSBTAG00000049434","energy","MCT1 can be upregulated by PPAR-¦Á, Nrf2, and AMPK,Monocarboxylate transporters (MCT) catalyze the bidirectional proton-linked transport of short-chain monocarboxylates such as L-lactate, ketone bodies and pyruvate across the plasma membrane of mammalian cells. MCT1-4 are key in the regulation of many cellular processes.","SLC16A1","ENSBTAG00000049434","monocarboxylate transporter 1 ",2.43,1.28,0.02,0.05,"up","GO:0008028(monocarboxylic acid transmembrane transporter activity);GO:0015718(monocarboxylic acid transport);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport)",NA,"K08179",NA,"yes"
"162","Energy metabolism","ENSBTAG00000000697","energy response","Essential component of the eNoSC (energy-dependent nucleolar silencing) complex","","RRP8","ribosomal RNA processing 8 ",0.45,-1.16,0,0,"down","GO:0000183(chromatin silencing at rDNA);GO:0005634(nucleus);GO:0005677(chromatin silencing complex);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006364(rRNA processing);GO:0008168(methyltransferase activity);GO:0016740(transferase activity);GO:0032259(methylation);GO:0033553(rDNA heterochromatin);GO:0035064(methylated histone binding);GO:0042149(cellular response to glucose starvation);GO:0046015(regulation of transcription by glucose);GO:0071158(positive regulation of cell cycle arrest);GO:0072332(intrinsic apoptotic signaling pathway by p53 class mediator)",NA,"K14850","EC:2.1.1.287","yes"
"165","Energy metabolism","ENSBTAG00000013921","Mito metabolism","cytoplasmic enzyme involved in energy homeostasis","","CKM","creatine kinase, M-type ",6.88,2.78,0,0,"up","GO:0000166(nucleotide binding);GO:0003824(catalytic activity);GO:0004111(creatine kinase activity);GO:0005524(ATP binding);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0009408(response to heat);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0016772(transferase activity, transferring phosphorus-containing groups);GO:0046314(phosphocreatine biosynthetic process);GO:0046314(phosphocreatine biosynthetic process)","00330(Arginine and proline metabolism);00330(Arginine and proline metabolism)","K00933","EC:2.7.3.2","yes"
"166","Energy metabolism","ENSBTAG00000021307","mitophagy/autophagy","argets mitochondria and causes apoptotic changes, including loss of membrane potential and the release of cytochrome c.","","BNIP3L","BCL2 interacting protein 3 like ",3.32,1.73,0,0,"up","GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005739(mitochondrion);GO:0005740(mitochondrial envelope);GO:0005741(mitochondrial outer membrane);GO:0005783(endoplasmic reticulum);GO:0006915(apoptotic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0035694(mitochondrial protein catabolic process);GO:0043065(positive regulation of apoptotic process);GO:0051607(defense response to virus);GO:0097345(mitochondrial outer membrane permeabilization)","04137(Mitophagy - animal)","K15465",NA,"yes"
"171","cell growth/transcription elongation","ENSBTAG00000047225","apoptosis"," induce apoptosis","","BCL2L14","BCL2 like 14 ",2.51,1.33,0.02,0.05,"up","GO:0005829(cytosol);GO:0006915(apoptotic process);GO:0019901(protein kinase binding);GO:0042981(regulation of apoptotic process);GO:0043229(intracellular organelle)",NA,NA,NA,"yes"
"172","cell growth/transcription elongation","ENSBTAG00000012567","cell growth","cellular senescence","","TERT","telomerase reverse transcriptase ",178.98,7.48,0,0,"up","GO:0000049(tRNA binding);GO:0000333(telomerase catalytic core complex);GO:0000781(chromosome, telomeric region);GO:0000784(nuclear chromosome, telomeric region);GO:0001172(transcription, RNA-templated);GO:0001223(transcription coactivator binding);GO:0003677(DNA binding);GO:0003720(telomerase activity);GO:0003721(telomerase RNA reverse transcriptase activity);GO:0003723(RNA binding);GO:0003964(RNA-directed DNA polymerase activity);GO:0003968(RNA-directed 5'-3' RNA polymerase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0005697(telomerase holoenzyme complex);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006278(RNA-dependent DNA biosynthetic process);GO:0007004(telomere maintenance via telomerase);GO:0007005(mitochondrion organization);GO:0008022(protein C-terminus binding);GO:0010629(negative regulation of gene expression);GO:0016605(PML body);GO:0016607(nuclear speck);GO:0016740(transferase activity);GO:0016779(nucleotidyltransferase activity);GO:0022616(DNA strand elongation);GO:0030177(positive regulation of Wnt signaling pathway);GO:0030422(production of siRNA involved in RNA interference);GO:0031379(RNA-directed RNA polymerase complex);GO:0031647(regulation of protein stability);GO:0032092(positive regulation of protein binding);GO:0042162(telomeric DNA binding);GO:0042635(positive regulation of hair cycle);GO:0042645(mitochondrial nucleoid);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0046326(positive regulation of glucose import);GO:0046872(metal ion binding);GO:0047485(protein N-terminus binding);GO:0051000(positive regulation of nitric-oxide synthase activity);GO:0051087(chaperone binding);GO:0070034(telomerase RNA binding);GO:0070200(establishment of protein localization to telomere);GO:0071456(cellular response to hypoxia);GO:0071897(DNA biosynthetic process);GO:0090399(replicative senescence);GO:0098680(template-free RNA nucleotidyltransferase);GO:1902895(positive regulation of pri-miRNA transcription by RNA polymerase II);GO:1903704(negative regulation of production of siRNA involved in RNA interference);GO:1904751(positive regulation of protein localization to nucleolus);GO:1990572(TERT-RMRP complex);GO:2000648(positive regulation of stem cell proliferation);GO:2000773(negative regulation of cellular senescence);GO:2001240(negative regulation of extrinsic apoptotic signaling pathway in absence of ligand);GO:2001240(negative regulation of extrinsic apoptotic signaling pathway in absence of ligand)","05165(Human papillomavirus infection);05166(Human T-cell leukemia virus 1 infection);05200(Pathways in cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05226(Gastric cancer)","K11126","EC:2.7.7.49","yes"
